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Pneumatic tourniquets are commonly used to produce bloodless operating 
fields in lower limb and hand surgery. Until recently, relatively 
little attention has been paid to the possibility that the tourniquet 
may cause neuromuscular damage. Although a low incidence of permanent 
neuromuscular damage has been reported, recent studies suggest that 
partial muscle denervation, lasting for several months, may be present 
in 71% of patients undergoing surgery involving the use of a tourniquet 
(Dobner and Nitz 1982). 
This thesis, includes two studies designed to investigate different 
problems in the use of the pneumatic tourniquet. The first investigated 
the use of local hypothermia to protect the ischaemic muscle during a 
prolonged tourniquet application; the second studied the accuracy of the 
automatic tourniquet pressure apparatuses in regular clinical use in 
Western Cape hospitals. 
(i) Studies of the effect of local hypothermia on tourniquet-induced 
muscle ischaemia 
Al though local hypothermia has been advocated as a method to increase 
tourniquet time safely from two to four hours ( Seki 1980), 11 ttle ex-
perimental data has yet been collected to prove the efficacy or other-
wise of this procedure. Thus an animal model was devised in which the 
effect of hypothermia on skeletal muscle made ischaemic by the use of 
the tourniquet was compared to ischaemic muscle that was kept at room 
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temperature. Under general anaesthesia, the upper limbs of 21 Landrace 
pigs were subjected to a tourniquet application of three hours at 500 
mmHg pressure, the opposite limb acting as a control. In ten pigs 
(hypothermic group), the tourniquet (ischaemic) limb was cooled by 
surrounding it with cold packs; the ischaemic limbs of the remaining 11 
pigs (control group) were exposed to room temperature. Measurements 
made included serum lactate, sodium, potassium and calcium levels, 
serum pH, creatine kinase activity and nasal, skin and muscle tempera-
tures before, during and after tourniquet application. Muscle biopsies 
were taken from muscle below the site of the tourniquet before the 
application and at ten minutes after release of the tourniquet. The 
muscle biopsies were stored in liquid nitrogen for subsequent analysis 
for glycogen content and phosphofructokinase activity. The pigs were 
monitored for six days after surgery before being re-anaesthetised for a 
second tourniquet application to the same limb at 500 mmHg pressure for 
two hours, but without the application of hypothermia. Muscle biopsies 
were again taken prior to and ten minutes after tourniquet release. 
Four days later, the pigs were sacrificed with an overdose of pen-
thothal. Muscle biopsies were taken from both the limb which had had 
the two tourniquets applied and the control limb. 
These experiments established the following : 
1. When compared to the normothermic ischaemic limb, the hypothermic 
ischaemic limb had higher pH, lower venous lactate levels and a 
slower rate of muscle glycogen utilisation. These findings 
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indicate that hypothermia reduced oxygen-independent glycolysis 
during tourniquet application. 
2. On tourniquet release, potassium levels in the venous effluent 
blood draining the hypothermic, ischaemic limb were lower than 
those measured in the blood draining the control, ischaemic limb. 
This indicates that the hypothermia reduces the extent of tourni-
quet-induced muscle cell damage. 
3. The muscle and skin temperatures of the ischaemic hypothermic limb 
returned rapidly to control values on tourniquet release, whereas 
these temperatures in the normothermic ischaemic limb remained 
significantly elevated. This indicates that hypothermia prevented 
the development of a marked tourniquet-induced inflammatory 
response 
4. Muscle glycogen and phosphofructokinase activities were signifi-
cantly higher ten days after the initial tourniquet in the hypo-
thermic, ischaemic limbs, whereas these values were reduced in the 
normothermic, ischaemic limb. This indicates that hypothermia 
preserved the viability of muscle subjected to two prolonged 
ischaemic insults. 
These findings provide strong evidence that (i) the prolonged appli-
cation of a tourniquet produces significant muscle damage and (ii) that 
locally-applied hypothermia decreases the magnitude of this damage. The 
\ 
nature of this protective effect is uncertain but may relate to the 
slowing of metabolic rate during ischaemia and a reduced inflammatory 
response during recovery. 
/ 
VII 
(ii) Study of pneumatic tourniquet apparatus in clinical use. 
Thirteen tourniquet apparatuses in clinical use in Western Cape hos-
pitals were studied. A protocol was drawn up which measured the 
accuracy, stability and the pressure compensation mechanism of the ap-
paratuses. A thorough visual examination for any external damage was 
also carried out at the same time. Only two of the machines were found 
to work satisfactorily. Of the remaining eleven, eight had inaccurate 
gauges when measured against an accurately calibrated pressure mano-
meter, and the remainder showed defeetive pressure compensation mechan-
isms. 
This study demonstrated a need for such a standard protocol to check all 
tourniquet apparatuses in clinical use. Recommendations from this study 
have been made to the various hospitals and it is hoped that this will 
help decrease the risk of the tourniquet procedure by removing defective 
equipment from regular use. 
(iii) Further Studies 
The study concludes by considering further research areas into the 
effects of tourniquet application. 
these findings are currently underway. 
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INrRODUCTION AND SCOPE OF THE STUDY 
"Anoxia not only stops the machine, it wrecks the whole machinery". 
Haldane 1926 
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As an anaesthetist, I have often watched the pneumatic tourniquet or 
Esmarch constrictive bandage being wrapped around a patient's limb. It 
seemed to me that the force with which the bandage was applied, or the 
pressure at which the pneumatic cuff was set, were chosen somewhat arbi-
trarily. Similarly, I noted that various surgeons had different opin-
ions about t;he "safe" duration of tourniquet application. In my experi-
ence, these opinions ranged from thirty minutes to four hours. However, 
I could find no literature describing in full detail the hazards of what 
has become an extremely common surgical procedure. Thus I began to 
compile a comprehensive review of the literature on the effects of 
tourniquet application on neuromuscular and vascular function. 
Whilst the pneumatic tourniquet is an invaluable aid to the surgeon, 
lessening the muscular damage caused by the tourniquet is of great im-
portance to the sportsman undergoing surgery, to expedite his or her 
rehabilitation and early return to sport. Thus, it became apparent to 
me that a method for increasing the safety of the tourniquet application 
was required. It seemed logical that, as a start, one should look at 
the protective effect local cooling of a limb with chemical ice packs 
would have on a muscle undergoing a prolonged tourniquet application. 
Chemical ice packs used in the study reported, have the advantage that 
they do not create a mess in the operating theatre, they are easily 
applied to the ischaemic limb, and they allow easy access to the opera-
tion site. Use of the commercially available ice packs in this way has, 
to my knowledge, not been reported previously. Thus, the following 
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studies were undertaken, based on my dual interests 
(i) as an anaesthetist frustrated by the lack of a comprehensive 
review and recommendations on the effects of the pneumatic 
tourniquet, and 
( ii) as a sportsman worried about the effect on the athlete's re-
habilitation after operations involving the use of the 
tourniquet. 
The following thesis is the result of those studies. 
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CHAPTER TWO 
A REVIEW OF THE LITERATURE ON THE EFFECTS OF TOURNIQUET APPLICATION 
ON VARIOUS MORPHOLOGICAL, BIOCHEMICAL AND PHYSIOLOGICAL PARAMETERS. 




2.1 HisrORICAL BACKGROUND 
Constriction devices to control haemorrhage have been used since at 
least Roman times. The name "tourniquet" was first used by Jean Louis 
Petit in 1718 to describe his compression screw for haemostasis (tourner 
= French "to turn") and various modifications of Petit' s apparatus re-
mained in use until the end of the 19th Century. Lister, in about 1864, 
was the first surgeon to describe the use of the tourniquet for surgery, 
other than amputation, when he operated on a tuberculous wrist joint. 
He expressed pleasure at the bloodless operating conditions the tourni-
quet created. t.ister also emphasised the importance of elevating the 
limb prior to tourniquet application to drain the venous blood from the 
limb (quoted by Klenerman 1962). 
In 1873 the use of the flat rubber bandage tourniquet was introduced by 
Professor Johann Friedrich August von Esmarch, Professor of Surgery at 
Kiel. He also described the use of his bandage as a means of expressing 
venous blood from the limb, an application still in use today (Esmarch 
1873). 
In 1904 Harvey Cushing introduced the pneumatic tourniquet, abandoning 
the rubber tourniquet of Esmarch because of the danger of nerve palsy 
and the difficulty in its re-application during an operation. With 
minor modifications, the Esmarch bandage and the gas pressurized pneu-
matic cuff remain the main methods for creating and maintaining a blood-
less field for limb surgery, the limb first being exsanguinated by 
either elevation or the use of the Esmarch bandage. 
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2.2 PRESENT DAY USE OF THE TOURNIQUET 
In modern practice, the tourniquet is used for various procedures 
( 1) Tumours of the limbs. There is evidence that dissemination of 
tumour emboli is reduced when biopsy or amputation for malignancy 
is carried out in a 'bloodless field' (Peltier, 1956). 
(2) Regional chemotherapeutic perfusion of limbs (Creech et al., 
1958). 
(3) To control the flow ·of blood during operations on the scalp 
(Orticochea, 1977). 
( 4) The creation of a bloodless field for limb surgery. This is the 
most common modern application for the tourniquet. 
At present, in North America, an estimated 10,000 pneumatic cuffs are 
used annually in more than one million surgical procedures (Kidde Com-
pany, 1979 - quoted by McEwan and McGraw 1982). Although no figures are 
available for South Africa, it is reasonable to assume that, on a per 
capita basis, similar numbers are involved. 
It is also apparent that complications do occur due to the pneumatic 
tourniquet and may be more frequent than previously suspected. Dobner 
and Nitz (1982) reported that 71% of 24 patients undergoing menisec-
tomies under tourniquet ischaemia, had abnormal electromyographic find-
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ings six weeks after operation. Similar results were found by 
Weingarden et al. (1979). Muscle strength, measured by maximum iso-
metric tension development, contraction and half relaxation times, of 
the muscles lying under and distal to a tourniquet, was reported by 
Patterson and co-workers (1981). Six days after a three hour tourni-
quet, compressed muscle tension was reduced to approximately 80% of the 
control value whilst, in the distal muscle, tension development varied 
from normal to 64% of the control value. They concluded that muscle 
strength recovery may take more than a week to recover after a three 
hour tourniquet application. Thus, several authors have advised that 
the tourniquet be avoided where possible, especially if the person in-
volved is a trained athlete who wishes to make an early return to his or 
her sport (Dobner and Nitz 1982, Eriksson 1981). Ward (1976), reporting 
the avoidance of tourniquet use by the elevation of the hand being oper-
ated upon, noted a marked decrease in post-operative swelling and 
earlier return to function. 
However, many surgeons still believe that the procedure of tourniquet 
application is extremely safe and reliable. They contend that the pro-
cedure causes very few clinical complications whilst affording a clear 
surgical field at operation. Thus, it seems likely that the pneumatic 
tourniquet will continue to be used for even minor procedures in the 
foreseeable future. This being the case, it becomes essential to tmder-
stand the potential complications of this procedure and to develop tech-
niques that can reduce or even eliminate these risks. 
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2. 3 MORPHOLOGICAL DAMAGE TO MUSCLES 
Harman (1947) was one of the first to describe marked changes in skele-
tal muscle fibres after tourniquet application for between two to four 
hours on rabbit hind limbs. He showed that the longitudinal striations 
present in the fibres disappeared after two to four hours' ischaemia and 
cross striations became conspicuous. Longer ischaemic periods of up to 
18 hours were associated with the appearance of anisotropic Bowmans 
discs, which he considered to be "true degenerative forms and not arte-
facts caused by fixation and sectioning". 
Solonen and Hj el t (1968), in human striated muscle and Heppenstall et 
al. (1979) in the quadriceps muscles of dogs, noted granular degenera-
tion in the muscle cells after 30 minutes of tourniquet ischaemia. 
These changes were even more marked after one hour of tourniquet appli-
cation. Capillary damage was also noted after thirty minutes, but 
minutes, but remained mild un ti! about two hours' ischaemia when hya-
linisation and an increase in the inflammatory cell reaction was noted. 
Interstitial oedema was present after one hours' tourniquet application 
and, after two hours, was more marked and associated with haemorrhage. 
Twenty-four hours after tourniquet release the oedema had progressed 
further (Harman, 1947, Heppenstall et al. 1979). 
J 'ozsa and co-workers (1980) performed serial biopsies on the intrinsic 
hand muscles of patients undergoing reconstructive surgery under tourni-
quet ischaemia. They found only limited ultrastructural alterations 
after an ischaemia time of up to 120 minutes. Except for a reduction in 
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the number of glycogen granules in both red and white fibres, they found 
no immediate effect of ischaemia on any other component of the fibres. 
Mitochondrial, myofilamental and nuclear alterations were N<Jr found. 
However, there was extracellular oedema which increased in severity with 
the duration of tourniquet application. Swelling of the endothelial 
cells was present after 30 minutes and was associated with obliteration 
of the capillary lumen, although extravasation or disruption of the 
capillary wall was not observed. 
In rhesus monkeys, Patterson and Klenerman (1979) reported that more 
damage occurred to those ti.ssues directly under the tourniquet than at 
distal sites. In contrast to the findings of J'ozsa et al. (1980), they 
noted that the mitochondria appear to be very sensitive to ischaemia, 
and showed changes within one hour of tourniquet application. Mitochon-
drial structure returned to normal only three days after a three hour 
tourniquet application and seven days after a five hour application. 
Similar results were found by Tountas and Bergman (1977). 
It has been reported that white Type II (fast twitch) muscle fibres may 
be more protected from an ischaemic insult than are red, Type I ( slow 
twitch) fibres, possibly because they contain fewer mitochondria 
(Jennische et al. 1979). However, Heppenstall et al. (1979) and J'ozsa 
et al. (1980) were unable to find any difference between the tolerance 
of slow and fast twitch muscle fibres to ischaemia. 
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SUMMARY OF MORPHOLOGICAL DAMAGE TO MUSCLES 
The reports differ with respect to the time of onset and extent of the 
damage caused by tourniquet ischaemia. This may be due to differences 
in the various muscles biopsied, the different animal species used and 
the different sites at which the muscles were biopsied, whether distal 
to, or directly beneath the tourniquet. Consistent findings were oedema 
and associated capillary endothelial damage starting within half an hour 
of tourniquet application. This oedema increased in severity with the 
duration of the application and continued for at least 24 hours after 
tourniquet release. Whether the different muscle fibres have different 
sensitivities to ischaemia awaits further study. 
2.4 NEUROLOGICAL DAMAGE 
A. Clinical Studies 
The incidence of clinically apparent nerve damage is difficult to 
determine as adequate prospective studies utilising large numbers 
of subjects have not yet been published. Early reports (Lej ars 
(1912), Eckhoff (1932), Bruner (1951) have warned of adverse 
effects to nerve function and Moldaver (1954) reported seven cases 
of tourniquet paralysis which he believed to be largely mechanical 
and not ischaemic in origin. 
A retrospective questionnaire survey by Middleton and Varian (1974) 
in Australia, provided an 'educated guess' that the average inci-
dence of tourniquet-induced peripheral nerve damage was 1 in 8,000 
operations. The figure was higher for the arm (1 in 5,000) than in 
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the leg (1 in 13,000). Sixty percent of the reported upper limb 
and all the lower limb palsies were caused by the use of the 
Esmarch bandage, and all except one tourniquet had been applied for 
less than 90 minutes. Only two paralyses failed to resolve com-
pletely; of th~ others, the majority recovered in four to five 
months, although some required up to 12 months for full clinical 
recovery. Although the validity of this survey and the assumptions 
made are open to criticism, it emphasises that tourniquet appli-
cation, especially with the Esmarch bandage, can cause serious 
damage to peripheral nerves. 
Rorabeck and Kennedy (1980) suggested that many tourniquet palsies 
were, in fact, not reported because of medicolegal implications; 
thus the true prevalence may be under-estimated. Indeed, success-
ful litigation for a tourniquet-induced paresis has been filed in 
the United States (Wachsman 1978). Rorabeck and Kennedy also pre-
sented case reports of five patients with sciatic nerve palsy. In 
one, the palsy had not completely recovered even six months after 
the tourniquet application. 
Incorrect pressure gauge readings have been associated with many 
nerve palsies (Prevosnik 1970, Fry 1972, Medical Devices Alert 
1978, Bruner and Calderwood and Dickie 1972, Flatt 1972, Hamilton 
and Sokol! 196 7). Rudge (1974) reported a case of total median, 
radial and ulnar nerve paralysis in a patient who had undergone 
tourniquet application for a total of 60 minutes, 40 minutes plus 
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20 minutes, separated by a four minute interval. The aneroid gauge 
of the pneumatic tourniquet used in this operation was stated to be 
accurate. After four-and-a-half months, only 50% of the median and 
ulnar nerve function had returned. 
Thus, complete 'tourniquet paralysis' is a well recognized compli-
cation of the procedure, but the incidence appears to be small and 
many surgeons may never see one such case in a lifetime (Funk, 
1980). It is reported that even though the motor deficit may be 
severe, there may be only minimal sensory loss (T roj aborg, 1977). 
The identification of minor degrees of muscle weakness in the face 
of normal sensation is difficult. However, recent electromyo-
graphic (EMG) studies are beginning to show the extent of the 'hid-
den' neuromuscular damage caused by the tourniquet. 
Saunders et al. (1979), reporting on a larger trial initiated and 
first-reported by Weingarden et al. 1979, evaluated limb EMG 
changes after tourniquet application. Forty-nine patients were 
evaluated six weeks after routine menisectomies, all of which were 
performed under tourniquet. Eighty-five percent of the patients 
with a tourniquet time of more than 60 minutes had EMG signs of 
motor denervation distal to the site of the cuff, usually involving 
muscles served by the femoral and posterior tibial nerves. Twenty-
two percent who had had a tourniquet time of less than 15 minutes 
also had abnormal EMG's (Table 1). An abnormal EMG was defined as 
the presence of positive sharp waves, with or without fibrillation 
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potentials, a decrease in the number of voluntary motor unit action 
potentials and an increase in the polyphasic nature of the motor 
unit action potentials. The abnormal EMG's took two to five months 
to resolve - the shorter the tourniquet time, the faster the 
recovery. 
Table 1 
EM.G Abnormalities six weeks' post-tourniquet (Saunders et al. 1979) 
No. Patients Tourniquet Time Abnormal EM.G's 
Number % 
13 60 minutes 11 85 
14 30 - 60 minutes 10 71 
12 15 - 30 minutes 7 58 
9 15 minutes 2 22 
A similar study by Dobner and Nitz (1982) reported EMG abnor-
malities in 17 (71%) of 24 patients six weeks after menisectomy 
under tourniquet. No statistical correlation was found between the 
duration of the tourniquet and the prevalence of abnormal EMG' s 
showing partial denervation. As in the study of Saunders et al. 
( 1979), the muscles supplied by the femoral and posterior tibial 
nerves were involved predominantly. One subject showed EMG abnor 
malities six weeks after a tourniquet application of eight minutes 
at a pressure of 340 mmHg. In a control group of 24 subjects who 
had had similar operations, but without a tourniquet, no evidence 
B. 
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of EMG abnormalities at six weeks or later was found. The two 
groups' functional capacity were measured by recording the height 
obtained with a one-legged jump test and by the maximum resistance 
generated by the quadriceps femoris muscle group during progressive 
resistive exercise. Tho.se subjects with no EMG abnormalities (i.e. 
7 out of 24 of the tourniquet group and all 24 of the non-tourni-
quet group), had functional capacities 71% and 79% respectively 
when compared with the non-operated leg. Those subjects who had 
EMG signs of denervation (71% of the tourniquet group and none in 
the no-tourniquet group) had functional capacities of only 39% when 
compared to the normal . leg. The differences in functional capaci-
ties persisted until the EMG abnormalities resolved, which took 
between three and six months. 
Femoral nerve conduction studies were carried out in 31 patients at 
six weeks post-tourniquet but were discontinued when no abnormali-
ties were found. The authors suggested that the six week period 
between the operation and the testing may have allowed any subtle 
conduction defects in the femoral nerve sufficient time to 
recover. 
Proposed Mechanisms and Sites of Neurological Damage 
Two main mechanisms are postulated as the cause of nerve damage 
following tourniquet application; the first i13 ischaemia, and the 
second is the pressure and shearing effect of the tourniquet. 
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The Ischaemic Insult 
Substrate depletion and the accumulation of the metabolites of 
hypoxia in ischaemic tissue can disrupt the normal electrolyte 
transfer both of the nerve itself and of the more sensitive motor 
unit (Lundborg, 1970). Confirmation of the role ischaemia may play 
was provided by Matsen and co-workers (1976) who used an airsplint 
inflated to 80 mmHg in awake volunteers. When the limb was eleva-
ted, ischaemia was increased and there was a greater slowing of 
nerve conduction and a greater decrease in evoked muscle action 
potentials. 
Some workers believe that the fastest conducting nerve fibres are 
more sensitive to ischaemia (Lundborg, 1970 and 1972, Fox and 
Kenmore, 1967); others (Nielsen and Kardel, 1974) that the slower 
nerve fibres are more sensitive, and yet others (Ruskin et al. 
1967) that ischaemia produces an equal decrease in conduction velo-
city in all nerve fibre types. On the other hand, Tamada and co-
workers (1981) have shown that the largest myelinated fibres are 
the first to be affected. Using awake human volunteers, they show-
ed that somatosensory evoked potentials (SEP) from Erbs point, 
which is served primarily by large myelinated fibres, were the 
first to fail. They also state that selective abnormalities of SEP 
could occur in disorders of the peripheral nerves, perhaps indi-
cating different sensitivities of the different myelinated fibres 
to various insults. 
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The general consensus is that the initial effect of an inflated 
cuff on nerve conduction is probably due to ischaemia and is 
rapidly reversed if the tourniquet application is brief (Lundborg 
1970, Yamada et al. 1981, Matsen et al. 1976). This does not, 
however, explain the persistant EMG abnormalities found in both 
Saunders et al. (1979) and Dobner and Nitz's (1982) studies in 
patients who had tourniquet times of less than 15 minutes. 
Direct Mechanical Pressure 
The second postulated cause of nerve damage is that it is due to the 
direct pressure, plus the shearing stresses created in the tissues by 
the tourniquet. 
Ochoa et al. (1972) investigated the damage caused by a tourniquet in-
flated to 1000 mmHg for 1 - 3 hours around the knees of baboons. Single 
teased fibres were studied in transverse sections under the electron 
microscope for up to six months after the tourniquet application. 
Their findings were : 
(a) In the first few hours after tourniquet release, nerve damage was 
restricted to areas underlying the edges of the cuff, suggesting 
that this was a result of direct pressure trauma. The early 
changes consisted of dislocation of the Nodes of Ranvier of the 
large myelinated fibres. Invagination of these Nodes was accom-
panied by the infolding of the myelin w1 th movement of the nodal 
axoplasm and axonal membrane away from the point of junction of the 
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two Schwann cells. Other changes, such as partial or complete 
rupture of the myelin lamellae in the invaginated area, were also 
seen. 
(b) By the end of the first week, demyelination had followed the in-
vagination, always in the direction away from the cuff towards 
uncompressed tissues, both distally and proximally. 
(c) The demyelination lesions which persisted for weeks and even months 
recovered by gradual remyelination. The authors were unsure 
whether this remyelination was due to lateral extension of myelin 
from an intact region, as proposed by Allt (1969), or whether the 
thin tapered myelin was due to the persistence of partial demye-
lination. 
(d) On recovery, the nerve showed a mixture of normal, demyelinated and 
thinly remyelinated fibres in the areas underlying the tourniquet 
cuff edges. No demyelination lesions occurred directly under the 
body of the cuff. 
These workers also studied nerves distal to the cuff but could find 
no evidence of demyelination after 2 - 3 hours' ischaemia with the 
cuff at 1000 mmHg pressure. 
Others have found that the application of high tourniquet pressures 
( 1000 mmHg) causes a conduction block in the nerves underlying the 
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tourniquet (Fowler et al. 1972, Gilliatt et al. 1974, Rorabeck 1980). 
Gilliatt et al. (1974) and Rorabeck (1980) both reported that conduction 
blocks appear to develop at the site of the nerve which had been direct-
ly under the proximal edge of the tourniquet cuffs. Gilliatt et al. 
(197 4) also reported that conduction blocks occurred under the distal 
edge of the tourniquet cuff in two of the four monkeys they studied. 
Rorabeck (1980) reported tha"t the duration of recovery in the sciatic 
nerve of dogs was directly proportional to the duration of the tourni-
quet application and the pressure to which the cuff was inflated. Simi-
lar results were found by Hurst et al. (1981) who examined conduction 
velocities of the median and ulnar nerves of humans after a tourniquet 
of 300 mmHg pressure. These authors found that the conduction velocity 
had returned to only 75% of pre-tourniquet levels even when measured two 
hours after release of the tourniquet. The delay was again localised to 
the area of the nerve which had been under the tourniquet. 
Ochoa and co-workers (1972) point out that the pressure gradient in the 
tissues would be greatest between the parts directly under the edge of 
the cuff and those on either side. Also, with a relatively wide cuff, 
the gradient would be maximal under the edges of the cuff and least at 
its centre. Rorabeck (1980) also suggests that this shearing force 
would be greatest at the proximal edge of the cuff due to the conical 
nature of the limbs of most of the experimental animals. The nerve 
itself appears to be very resistant to directly applied pressure as 
demonstrated by Grundfest (1936), who showed that pressures of over 1000 
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pounds per square inch were necessary to cause a conduction block in 
isolated frog nerves. 
Summary of Neurological Damage 
That complete nerve paralysis can follow tourniquet application is well 
reported, although the incidence would appear to be low. The paucity of 
reports may possibly be due to medico-legal considerations. On the 
other hand, the incidence of previously undetected partial muscle dener-
vation following a tourniquet application is reported to be extremely 
high, up to 71% in one series. This, coupled with the fact that the 
return to normal nerve and · muscle function may take up to six months, 
indicates that nerve damage caused by the tourniquet is a greater prob-
lem than previously suspected. 
Ischaemia and direct pressure to nerves seem to cause little lasting 
damage. However, the large shearing forces between the tissue under the 
edge of the tourniquet cuff and the non-pressurised tissue, which are 
exaggerated by the conical nature of the limb, appear to cause a de-
myelinating lesion in at least some of the nerve fibres tmderlying the 
tourniquet edge. Whether the demyelination lesions caused by cuff pres-
sures of 1000 mmHg occur in clinical practice, where lower cuff pres-
sures (500 mmHg) are used, remains to be established. 
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2. 5 METABOLIC AND BIOCHEMICAL CHANGES IN BLOOD AND SKELETAL MUSCLE OF 
THE ISCHAEMIC LIMB. 
A. Serum Creatine Kinase (CK) Activity 
Creatine kinase is found mainly in striated muscle (Tanzer et al. 
1959, Pausescu et al. 1976) and its .measurement in blood is used as 
an indicator of muscle injury. 
Chiu et al. (1976) measured CK levels in dogs who had undergone 
pneumatic tourniquet applications to their hind limb for periods of 
one, two or three hours. Control dogs showed only a slight rise in 
CK activity during anaesthesia. After the release of a one hour 
tourniquet, there was no significant difference in serum CK levels 
between controls and the dogs who had had tourniquets applied. 
After the release of a two hour tourniquet occlusion, there was a 
delay of up to an hour before the regional venous CK activity began 
to rise. It was suggested that this was due to the no-reflow phe-
nomenon as first proposed by Strock and Majno (1969). After a 
three hour tourniquet application, the CK activity in the first 
venous blood sample drawn 15 minutes after release had risen signi-
ficantly. These authors and others (Heppenstall et al. 1979), 
found that by releasing the tourniquet for 15 minutes every hour 
for three hours, the CK and pH re·sponded as if the tourniquet had 
been applied for only one hour. They concluded that interrupting 
the ischaemia time by 15 minutes in every hour, could safely pro-
long the tourniquet tim_e, and this would avoid excessive muscular 
damage. It should be noted that these workers monitored the CK 
B. 
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activity for only two hours after tourniquet release, whereas the 
CK activity continues to rise for 24 - 48 hours after tourniquet 
removal (Santavirta et al. 1978a). 
Chiu et al. (1976) postulate that CK is only released after a total 
period of three hours' ischaemia (i.e. either three hours' total 
tourniquet time, or two hours' tourniquet time plus one hour of no-
reflow after tourniquet release), and considered that one hour of 
total ischaemia caused minimal cellular derangement to the skeletal 
muscle of dogs. 
Modig et al. (1978) found no difference between the initial rise of 
CK in 15 patients who had had a tourniquet applied for approximate-
ly two hours and 76 controls undergoing anaesthesia without tourni-
quet. However, when the last blood samples were taken some 2t 
hours later, the CK levels were still rising and were higher in 
patients who had had tourniquets applied. 
Thus various authors have used serum CK activity as an index of 
muscle cell damage after _ tourniquet application. There appears to 
be a delayed rise in serum CK activity after two hours' ischaemia. 
After three hours' ischaemia, CK activity in the effluent blood 
rises rapidly after tourniquet release. 
Skeletal Muscle High Energy Phosphate Content 
Several authors have reported only moderate or no lowering of ade-
nosine triphosphate (ATP) tissue levels after up to two hours' 
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tourniquet application (Haljamae and Enger 1975, Larsson and 
Hultman 1979, Stock and Isselhard 1972, Haggmark et al. 1981). 
Phosphocrea;ine levels, however, begin to fall after four minutes 
and reach 32% of control levels 20 minutes after the start of is-
chaemia (Harris et al. 1975). The fall in phosphocreatine levels 
is progressive, reaching 60% of the baseline levels, 60-90 minutes 
after the onset of ischaemia, and being almost completely depleted 
after two hours' ischaemia (Larsson and Hultman 1979, Haljamae and 
Enger 1975). The rate of phosphagen depletion appears to decrease 
with increasing tourniquet time, possibly due to a fall in tempera-
ture of the ischaemic limb (Halj amae and Enger 1975). After 
tourniquet release, the return to baseline phosphocreatine levels 
is rapid; within five minutes after an ischaemic time of up to two 
hours (Haljamae and Enger 1975, Larsson and Hultman 1979). 
A tourniquet time of three hours and more caused falls in adenosine 
triphosphate, as well as in phosphocreatine levels. Stock et al. 
(1971) showed almost complete breakdown of phosphagens after three 
hours' tourniquet in rats. The levels were still somewhat lower 
than the baseline even after a one hour recovery period. After 
four hours' tourniquet ischaemia, normalisation of tissue phospha-
gen levels required several weeks and, even after three weeks, 
phosphocreatine levels were only 76% and adenosine triphosphate 
levels only 3 7% of pre-tourniquet levels. In these experiments, 
the decrease in temperature of the ischaemic limb was prevented by 
maintaining the environmental temperature at 28°C. 
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Stock and Isselhard (1972) caused renal failure and tourniquet 
shock on release of a five hour tourniquet application. There was 
almost complete phosphocreatine depletion after two to three hours' 
ischaemia and, at the end of the five hours, the ATP level was only 
30% of the control. On release of the tourniquet, phosphocreatine 
but not adenosine triphosphate showed significant recovery. 
Jennische et al. (1979) subjected cat hind limbs to two hours' 
tourniquet ischaemia and found different degrees of phosphagen 
depletion in red, slow twitch (Type I) and white, fast twitch (Type 
II) fibres. Type II fibres showed no significant decrease in ATP 
or phosphocreatine levels after two hours' ischaemia, but a 40% 
decrease was seen in phosphagen levels in Type I fibres. This may 
be due to the red Type I fibres' dependency on aerobic metabolism, 
whereas the Type II fibres are better adapted for oxygen-indepen-
dent glycolysis. 
Miller and co-workers (1979) have suggested that the anatomical 
location of the muscle with respect to the site of tourniquet ap-
plication, is important in assessing the effect of tourniquet 
ischaemia. In monkeys, 24 hours after a 2t hour tourniquet, they 
found a significant fall in phosphocreatine levels in the vastus 
lateralis muscle, but not in the anterior tibial muscle. They 
postulated that this probably reflected a direct crush injury by 
the tourniquet to the vastus lateralis muscle. 
c. 
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Thus, it seems that the muscle phosphocreatine content is rapidly 
depleted during tourniquet ischaemia. Adenosine triphosphate 
levels are, however, well preserved \llltil after two hours' tourni-
quet application. Thereafter these levels also begin to decline. 
The rate of recovery to pre-tourniquet phosphocreatine and adeno-
sine triphosphate levels is proportional to the duration of tourni-
quet application. Several weeks are required before normalisation 
of phosphagen stores after a four hour tourniquet application. 
Other factors, such as differing muscle fibre types and the type of 
trauma, whether ischaemic or ischaemic plus pressure, also appear 
to be important. 
Skeletal Muscle Glycogen Content 
Marked decreases in muscle glycogen, proportional to the duration 
of tourniquet ischaemia have been shown (Larsson and Hultman 1979, 
Stock et al. 1971). The rate of recovery of glycogen stores to 
pre-tourniquet levels is also proportional to the tourniquet 
duration. After a 4 hour tourniquet, muscle glycogen levels took 6 
weeks to return to normal and, after· a 5 hour tourniquet applica-
tion on dogs, there was little sign of any recovery (Stock et al. 
1971). 
D. Blood Glucose Levels 
Glucose levels of the blood in the ischaemic limb consistently fell 
to 23% of pre-ischaemic levels after 30 minutes of tourniquet is-
chaemia in monkeys (Dery et al. 1965). 
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E. Lactate Levels 
Muscle Lactate Levels 
Significant increases in muscle lactate levels, within 60 - 90 
minutes of tourniquet induced ischaemia, have been reported 
(Raljamae et al. 1975, Raggmark et al. 1981, Jennische et al. 
1979). Experimental and clinical findings by Larsson and Hultman 
( 1979) showed a 10 - 20 times rise in muscle lactate production 
between the second and third hour of tourniquet ischaemia. This 
corresponds closely to the lowest values of muscle glycogen found 
in rat and dog experiments (Stock et al. 1971, Stock and Isselhard 
1972). 
On release of a 90 - 150 minute tourniquet application, muscle 
lactate levels fall gradually (Larsson and Hultman 1979). The 
levels are still raised 5 minutes after tourniquet release but are 
normal when measured 30 minutes later. Raljamae and Enger (1975) 
reported a complete return to normal muscle lactate levels, five 
minutes after tourniquet ischaemia of up to 60 - 90 minutes in 
humans. However, in dogs, approximately one hour was needed for 
tissue lactate normalisation after a 3 hour period of experimental 
tourniquet ischaemia (Haljamae and Enger 1975). 
Blood Lactate Levels 
In monkeys, Dery and co-workers (1965) found no change in venous 
lactate levels for the first 30 minutes after tourniquet release. 

























lactate levels in the first venous sample drawn from the limb after 
removal of the tourniquet (Heppenstall et al. 1979, Halj amae and 
Enger 1975, Dahlback 1970) • 
The correlation between the duration of ischaemia and the time 
needed for the lactate to return to pre-tourniquet levels after 
tourniquet release, has been suggested as evidence of both the 
existence and the severity of a partial no-reflow phenomenon 
(Dahlback et al. 1970, Harman 1948, Strock and Majno 1969). 
Heppenstall et al. ( 1979) reported that releasing the tourniquet 
for ten minutes every hour prevented the immediate elevation of 
blood lactate after a 3 hour tourniquet application. This suggests 
that regular hourly release of the tourniquet prevents an accumu-
lation of the products of oxygen-independent glycolysis. The blood 
lactate/pyruvate ratio in the muscle of the ischaemic limb is sig-
nificantly increased during the tourniquet application and for the 
first few hours after tourniquet release (Dery et al. 1965, Enger 
et al. 1978), confirming oxygen-independent glycolysis which con-
tinues after tourniquet release • 
After 4 or more hours of ischaemia, muscle cells are morphologi-
cally changed and areas of anoxic tissue remain, thus prolonging 
the return to resting lactate levels (Chiu et al. 1976, Rhamer et 
al. 1977, Stock and Isselhard 1972, Tountas and Bergman 1977). 





































lactate normalization, may be due to the combined effects of a slow 
washout from the tissue and continuing lactate production in hy-
poxic areas. 
Thus tourniquet ischaemia activates oxygen-independent glycolysis 
producing elevated lactate levels in muscle and in venous blood 
draining the ischaemic limb. The rate of lactate production 
appears to be greatest between the second and third hours' of con-
tinuous tourniquet application. Intermittent interruption of the 
tourniquet for 10 minutes in every hour appears to prevent a sig-
nificant lactate build-up. It has been proposed that the slow 
equilibration between tissue and blood lactate levels after tourni-
quet release indicates the no-reflow phenomenon. Persistently 
elevated lactate levels after tourniquet release may indicate se-
vere alterations in muscle cell metabolism. 
F. Blood Acid-Base Levels 
Hydrogen Ion Concentration 
During the tourniquet application, features of gross metabolic 
acidosis occur, the pH of the blood in the ischaemic limb falls 
from 7,38 to pH 7,1 after 30 minutes and to pH 6,6 after two hours 
(Dery et al. 1965). Similar results were reported by Shaw-Wiglis 
(1971). 
The time for normalisation of venous pH after a one hour tourniquet 


















1971), 25 - 30 minutes in dogs (Chiu et al. 1976), and 20 minutes 
in rhesus monkeys (Klenerman et al. 1980). After a two hour tour-
niquet application, the return to baseline pH took between 13 
minutes (Shaw-Wiglis 1971) and 30 - 40 minutes (Modig et al. 1978, 
Klenerman et al. 1980). 
Heppenstall and co-workers (1979) measured tissue pH using a Gore-
Tex tube implanted in the muscle distal to the tourniquet. They 
showed a greater degree of acidosis in the tissues than in the 
blood, possibly because of the greater buffering capacity of blood. 
The tissue pH fell from a baseline of 7, 40 to pH 7, 0 after one 
hour, to a pH of 6,6 after two hours and to a pH of 6,5 after three 
hours. On release of the tourniquet, the rate of return to base-
line pH levels was proportional to the duration of the tourniquet 
application, taking 15 - 20 minutes to normalise after a three hour 
tourniquet. A concomitant rise in tissue pC02 also occurred with 
maximal value of 75 mm.Hg after three hours' ischaemia. 
Bicarbonate Concentration 
In monkeys, tourniquet ischaemia caused the bicarbonate concentra-
tion to fall steadily until there was almost complete exhaustion of 
the buffer reserve after three hours. Three minutes after release 
of a two hour tourniquet, the bicarbonate and base excess reached 
their lowest mean values (Modig et al. 1978) and then followed the 
same time course of return to baseline as did the pH. Klenerman et 
G. 
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al. (1980) reported that the bicarbonate concentration took 20 min-
utes to return to control values after a three hour tourniquet. 
These studies indicate that the acidosis caused by anaerobic meta-
bolism in the ischaemic tissues increases with the duration of the 
tourniquet application. The pH of the blood in the ischaemic limb 
falls less than the pH of the tissues, probably due to its increas-
ed buffering capacity. However, the blood bicarbonate buffer re-
serve appears to be completely exhausted after three hours' tourni-
quet. The rate of recovery of the blood and tissue pH of the is-
chaemic limb to pre-tourniquet levels, is also proportional to the 
duration of the tourniquet application. 
Oxygen Tensions 
In Tissue 
The P02 of a saline solution which is slowly perfused through a 
silastic tube implanted in the hindlimbs of a rabbit (method of 
Niinikowski and Hunt 1972) has been used as an indicator of tissue 
P02• Using this technique, Santavirta et al. (1976), found that 
the tissue P02 of rabbit muscle rendered ischaemic by three hour 
tourniquet applications, dropped to a minimum of 9 - 11 mmHg after 
19 - 26 minutes and remained at this level for three hours. Tissue 
P02 returned to pre-tourniquet levels within 10 - 17 minutes, re-
gardless of the length of tourniquet application. Tissue P02 rose 
rapidly when 100% 02 was inhaled. The authors concluded that, even 
after three hours of tourniquet ischaemia, the micro-circulation 
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functioned normally. Similar conclusions ~re drawn from studies 
of humans (Romanus et al. 1978). 
Heppenstall et al. (1979) implanted a Gore-Tex membrane (a tetra-
fluorocarbon tubular membrane) in the quadriceps of dogs and per-
fused it with hypoxic fluid to measure the pH and P02 of the efflu-
ent. After 20 minutes of tourniquet application, they reported 
that the tissue P02 was zero. The time taken to return to baseline 
P02 after tourniquet release depended on the tourniquet duration 
and was 10 minutes following one hours' ischaemia, 12 - 15 minutes 
after two hours' and .15 - 20 minutes after a three hours' ischae-
mia. They postulated that the delayed recovery of P02 due to 
arterio-venous shunting as well as to increased muscle oxygen con-
sumption following tourniquet release. Similarly, Miller and co-
workers (1978), used an implanted teflon diffusion membrane and 
showed that muscle P02 fell to very low levels of 3,0 mmHg after It 
hours of tourniquet ischaemia. The return to control levels took 
30 - 45 minutes after a 2t hour tourniquet application. 
In Blood 
Shaw-Wilgis (1971) reported a marked fall in the venous P02 of the 
ischaemic limb from 45 mmHg to 4 mmHg after two hours of tourniquet 
application. The recovery time of P02 after removal of the tourni-
quet was dependent on the tourniquet time, and was 5 - 10 minutes 
after a one hour tourniquet, and more than 15 minutes after two 
hours. Dery et al. (1965) found the venous P02 to drop as low as 5 
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mmHg after only 25 minutes of tourniquet ischaemia. They also 
found a rapid return to baseline POz levels within five minutes 
after 30 minutes' tourniquet ischaemia. Modig et al. (1978) repor-
ted that, in humans, venous POz returned to pre-tourniquet levels 
within three minutes after tourniquet ischaemia. 
Santavirta et al. (1978b) reported rapid equilibration between 
tissue and venous POz even after a three hour tourniquet. However, 
others (Miller et al. 1978, Heppenstall et al. 1979) report that, 
even after only one hours' ischaemia, tissue gas tensions returned 
to pre-ischaemic levels more slowly than did the blood gas 
tensions. 
Thus there is disagreement about the minimum values of tissue POz 
reached during ischaemia and the speed of return of the POz to pre-
tourniquet levels. Some authors report a rapid return, even after 
three hours' tourniquet ischaemia, but most agree that the recovery 
time is proportional to the duration of tourniquet application. 
H. Serum Potassium Levels 
Klenerman and co-workers (1980) recorded a significant rise in 
potassium levels in the venous blood of the ischaemic limb during 
the tourniquet application. These levels reached a plateau between 
three and four hours but rose further if the duration of tourniquet 
application was increased to five hours. This corresponded to very 
large increases in the extracellular potassium concentration sur-
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rounding ischaemic muscle cells found after three hours' 
ischaemia. 
On release of the tourniquet, only transient and relatively insig-
nificant rises in potassium levels in the systemic circulation have 
been found, presumably due to the large dilutional effect 
(Klenerman et al. 1980). The return of potassium levels to pre-
tourniquet values in the venous blood draining the limb took 20 
minutes after a tourniquet time of one hour, and 40 minutes after a 
tourniquet time of two to three hours (Klenerman et al. 1980). 
Others, (Dery et al. 1°965, Modig et al. 1978), found a longer re-
covery time of some 30 - 60 minutes, after a tourniquet time of 60 
minutes. 
Using Xe 133 washout techniques, Larsson and Bergstrom (1978), 
found that after tourniquet release, the peak blood flow and venous 
potassium level in the ischaemic limb after tourniquet release 
occurred at the same time, reaching maximum values one to two 
minutes after release of a two hour tourniquet. Venous potassium 
levels in blood draining the previously ischaemic limb v.iere still 
significantly raised 15 minutes after tourniquet release, but had 
returned to control values by 30 minutes. Jennische et al. (1982) 
found that although interstitial potassium levels fell rapidly in 
the first 15 minutes after release of a three hour tourniquet, they 
remained significantly elevated one hour later. 
33 
In summary, various authors have used venous potassium levels as an 
index of cell damage. After a tourniquet time of three hours, 
venous potassium levels take at least 30 - 40 minutes to return to 
control levels, whereas recovery of interstitial potassium levels 
takes even longer. 
I. Serum Calcium Levels 
J. 
K. 
Dery and co-workers ( 1965) reported a slight rise in serum total 
calcium levels, with a 10% fall in ionized calcium, in the 
ischaemic limb of monkeys after a 30 minute tourniquet application. 
Serum protein levels also increased. 
for these calcium changes. 
No explanation was offered 
Tourniquet shock, caused by a five hour tourniquet application in 
dogs, is associated with marked rises in serum calcium levels in 
dogs (Stock and Isselhard 1972). 
Serum Magnesium levels 
Stock and Isselhard (1972) reported marked increases in serum mag-
nesium in tourniquet-induced shock in dogs after mean tourniquet 
durations of five hours. 
Muscle Enzyme Activities 
Paakkonen and co-workers (1981) performed muscle biopsies distal to 
the tourniquet in eight patients who underwent menisectomies with 
average tourniquet times of 65 minutes. Biopsies of the vastus 
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lateralis muscles were taken prior to the tourniquet application, 
just prior to tourniquet release, and again ten minutes and three 
days later. These samples were assayed for the activities of suc-
cinyl dehydrogenase (SOH), creatine kinase (CK), phosphofructo-
kinase (PFK), malate dehydrogenase (MOH) and lactic dehydrogenase 
(LOH). 
They reported that muscle enzyme activities were unaltered during 
ischaemia, but ten minutes after tourniquet release, the SOH and CK 
activities were significantly lower, whereas PFK, MDH and LOH acti-
vities were unchanged. · By the third post-operative day, the CK, 
SOH, PFK and MDH activities were all lower and only LOH activity 
remained unchanged. SOH activity in the control limb also fell, 
probably reflecting a reduction in general physical activity in the 
initial post-operative period. Other workers, found no change in 
muscle SOH activity after two hours' tourniquet in man (Tountas and 
Bergman 1977). In rabbits, LOH activities were significantly de-
creased after 3 - 4 hours' tourniquet ischaemia (Santavirta et al. 
1978), possibly indicating that the tourniquet causes greater 
muscle damage in rabbits than in humans (Paakkonen et al. 1981), or 
that rabbit muscle is less resistant to ischaemic damage than is 
human muscle. 
These studies indicate that the early biochemical and enzymatic 
changes after tourniquet application are poorly documented. For 
example, the only two studies on succinyl dehydrogenase activity in 
L. 
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muscle after tourniquet application, have given conflicting re-
sults. Laboratory animals may also give results different from 
man, possibly because of large differences in the muscle mass ex-
posed to the tourniquet and in the differing muscle fibre types. 
Skeletal Muscle Electrolyte Changes 
Muscle Magnesium Levels 
Larsson and Bergstrom (1978) found no change in total magnesium 
content in muscle biopsies taken before and after two hours' tour-
niquet ischaemia. 
Muscle Sodium Levels 
Muscle sodium levels were unchanged either during or after a two 
hour tourniquet (Larsson and Bergstrom 1978). However, Enger et 
al. (1978) measured a 20% decrease in muscle membrane potential at 
the end of a three hour tourniquet application. This should have 
caused a 30 - 40% increase of intracellular sodium concentration. 
However they measured only a small rise in muscle sodium, reaching 
maximum levels in the first minute after tourniquet release. No 
explanation was offered as to why this rise was of such a low 
magnitude. 
Summary of Metabolic and Biochemical Changes 
The application of a tourniquet for longer than 30 - 60 minutes has 
pronounced effects on various metabolic and biochemical parameters 
measured in the ischaemic tissue. Hypoxia, shown by decreasing P02 
36 
levels, stimulates anaerobic glycolysis which increases muscle 
lactate levels, decreases muscle glycogen stores and increases 
hydrogen ion concentration. Eventually the decrease in pH exhausts 
the tissue and blood buffer reserves and interferes with cellular 
function, in particular the production of ATP. Once adenosine tri-
phosphate stores are depleted, normal cellular functioning is im-
paired and the membrane potential falls as potassium leaves and 
sodium enters the cells. With more prolonged hypoxia, possibly in 
conjunction with direct damage caused by the tourniquet pressure, 
intracellular enzymes such as creatine kinase, are released into 
the serum. 
Intermittent release of the tourniquet for 10 - 15 minutes every 
hour appears to decrease these adverse metabolic changes. Thus 
metabolic changes after a three hour tourniquet time are reported 
to be similar to those found after only a one hour application. 
2.6 VASCULAR CHANGES 
A. Haemodynamic Changes 
During the Tourniquet Application 
Klenerman and Crawley (1977) investigated the hypothesis that, 
despite the application of a tourniquet to the upper or lower limb, 
blood flow may persist via intramedullary canals (Furlow 1971, 
Spira et al. 1965). Using small microspheres labelled with 51 
chromium and measuring tissue washout of 22 sodium, they showed 
that blood flow in the tourniquet limb was less than 1% of the flow 
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to the control limb. They concluded that intramedullary canals are 
not physiologically significant. 
Romanus and co-workers (1978) used intravital microscopy to study 
the microcirculation in man during and after ischaemia. They found 
that during one and two hours of ischaemia, the trapped blood cells 
did not stick to each other or to the vascular walls, although some 
red blood cells tended towards rouleaux formation. After six hours 
of ischaemia, some red blood cells had formed homogenous masses 
indicating haemolysis; diapedeses of red blood corpuscles was also 
noted and there were signs of increased white blood cell sticki-
ness. 
Immediately After Tourniquet Removal 
Post-tourniquet Hyperaemia 
The pronounced increase in blood flow, after release of the tourni-
quet, has been ascribed to various mechanisms : 
(a) Increased levels of carbon dioxide, hydrogen ions, potassium, 
magnesium, lactate and pyruvate. 
(b) Reduced phosphagen stores of the vessel wall (Stock and 
Isselhard 1972). 
(c) Increased levels of other metabolites. 
( d) Increased blood osmolarity, which causes relaxation of vascu-
lar smooth muscle (Mellander et al. 1967). 
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Larsson and Bergstrom (1978) reported that venous osmolarity in-
creased 16 mosm/Kg HzO, one to two minutes after removal of the 
tourniquet. The increase in potassium, lactate and sodium levels 
accounted for 12 mosmoles and the remainder was due to moderate 
increases in glucose and calcium levels. The increased osmolarity 
was maximum one to two minutes after tourniquet release and this 
coincided with the maximal blood flow as measured by Xenon 133 
washout. Similar rises in osmolarity have been reported after soft 
tissue trauma to dogs' hind limbs (Sandegard et al. 1974). 
Using intravital microscopy, Romanus et al. (1978) demonstrated 
that circulation had returned to all vessels within seconds after 
release of a one to two hour tourniquet. The hyperaemic reaction 
lasted for about 30 minutes. There was also an early increase in 
the number of white blood cells sticking to the vascular walls but 
no thrombus formation or red blood cell diapedesis was seen. After 
a three to six hour ischaemic period, ref low occurred in all ves-
sels but was delayed for several minutes. Microthrombi were seen 
in one experiment, as well as marked white blood cell stickiness, 
red blood cell diapedesis and homogenous masses of red blood cells 
which slowed the re-perfusion rate. The longer ischaemic period 
also caused more marked oedema and endothelial damage. 
Delayed Changes After Tourniquet Release 
The hyperaemic period may end if there is excessive accumulation of 
oedema (Strock and Maj no 1969, Miller et al. 1979). Strock and 
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Majno (1969) noted a marked difference in the amount of skin and 
muscle oedema caused by a tourniquet application. The skin appear-
ed to accumulate more water than did the other tissues after a 
tourniquet time of as little as 30 minutes. This suggested that 
the hyperaemic response would be decreased, first in the skin and 
only then in the other tissues. 
Larsson and Lewis, 1978 used double-isotope-clearance techniques in 
25 patients who underwent knee surgery under tourniquet. They 
showed a smaller and later initial increase in blood flow on tour-
niquet release, when the tourniquet time exceeded 60 minutes. Nine 
of 16 legs showed a maximal transport function only one to two days 
post-operatively. 
Using intravital microscopy techniques, Romanus and co-workers 
(1978), examined the microcirculation of two subjects, 24 hours 
after six hours' tourniquet ischaemia. In one subject there was 
complete circulatory standstill whilst blood flow in the other was 
almost normal. These authors were unable to explain this differ-
ence and concluded that the final outcome of the six hour ischaemic 
insult remained uncertain. 
B. THE BLOOD CLarTING SYSTEM 
The Fibrinolytic System 
The fibrinolytic system appears to be stimulated by tourniquet 
application (Nakahara and Sakahashi 196 7), perhaps due to release 
of plasminogen activators from the vasa vasorum (Klenerman and 
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Crawley 1977). Thus, operations involving tourniquets appear to be 
associated with a lower incidence of deep venous thrombosis 
(Klenerman and Crawley 1977, Fahmy and Patel 1981, Kroese and 
Stiris 1976, Simon et al. 1982). This effect on fibrinolytic 
activity has even been used with some success to prevent deep lower 
limb venous thromboses by using intermittent compression of the 
arms (Knight and Dawson 197 6). A five hour tourniquet on dogs' 
hind limbs produced the appearance of deep-vein thrombosis in 
several of the 30 experimental animals which were divided into 
varying groups to assess the efficacy of heparin or low molecular 
weight dextran (Rhea and Foster 1961). Dextran given 30 minutes 
prior to tourniquet removal appeared to prevent the occurrence of 
the deep vein thrombosis. Heparin (3mg/Kg) intravenously 30 
minutes prior to tourniquet release was also reported to decrease 
the subsequent limb-oedema and swelling by almost 50%. However, 
other authors (Price et al. 1980) contend that in clinical practice 
the incidence of deep vein thrombosis after operations under tour-
niquet is no less than other lower limb procedures such as hip 
replacements (in which a tourniquet is not used). 
The possibility exists that this elevated fibrinolytic activity 
might be more likely to cause post-operative bleeding (Miller et 
al. 1979). For this reason, Newman and co-workers (1979) have 
suggested that a tourniquet should not be removed until a firm 
occlusive bandage had been applied. They reported that 400 ml more 
blood was lost when the tourniquet was removed prior to wound 
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closure, than when it was removed after closure. However, these 
patients had also been on low dose heparin as prophylaxis against 
deep vein thrombosis development, so their clotting ability may 
have been impaired. In contrast, Klenerman (1982) recommends early 
release of the tourniquet. He points out that if the tourniquet is 
released before wound closure, the blood loss is more readily 
measured and replaced while the patient is still in the operating 
theatre. However, if the tourniquet is left inflated until all the 
dressings and plaster have been applied, the patient may subse-
quently collapse because of an unrecognized 'hidden' blood loss. 
Pre-treatment of monkeys wit.h heparin prior to tourniquet applica-
tion prevented the consumption of fibrinogen and antithrombin III, 
but did not prevent an elevation of fibrin split products (Larsson 
and Risberg 1977, Risberg 1977). This suggested that non plasmin 
fibrinolytic agents, such as proteinases released by polymorpho-
nuclear leukocytes, may be important in increasing fibrinolytic 
activity. Increased plasminogen activity has been found in the 
blood draining the lower limbs during tourniquet ischaemia (Larsson 
and Risberg 1977, Fahmy and Patel 1981). The return of fibrinogen, 
antithrombin III and fibrin split products to pre-ischaemic levels 
took five minutes after tourniquet deflation. But fibrinolytic 
activity may be increased for up to 15 - 30 minutes after tourni-
quet release (Fahmy and Patel 1981, Klenerman and Crawley, 1977). 
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Platelet Aggregation 
Stebhens and Biscoe (196 7) described hydropic inclusion bodies in 
platelets, erythrocytes and endothelial cells during ischaemia. 
They postulated that these inclusion bodies may release adenosine 
diphosphate which would · cause increased platelet aggregation after 
tourniquet application. 
Romanus and co-workers (1978), however, found no thrombus formation 
in the microcirculation after one or two hours' ischaemia, although 
a six hour ischaemic period did produce a small adherent platelet 
thrombus in one subject. 
Zahavi et al. (1980) measured plasma thromboglobulin, a marker of 
in-vivo platelet reaction and plasma thromboxane Bz, a stable pro-
duct of thromboxane synthetase. They found an increase in both 
activities 15 - 30 minutes after tourniquet ischaemia in humans. 
In pig experiments they also showed reduced prostacyclin activity 
in blood draining from the ischaemic limb when compared to that 
from the control limb. When examined under a scanning electron 
microscope the veins of the ischaemic pig limb showed large de-
endothelialised areas covered with a monolayer of platelets and 
platelet clumps. However, these results may be animal specific as 
other workers (Strock and Majno with rats 1969, Solonen and Hjelt 
1968 and J'ozsa et al. 1980 with humans) have not reported similar 
endothelial damage or platelet layering. Zahavi et al. ( 1980) 
considered their results may explain the high incidence of venous 
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thrombosis affecting patients undergoing menisectomy and total knee 
replacement under tourniquet ischaemia. However, as already 
stated, a decreased incidence of deep vein thrombosis after opera-
tions involving the use of a tourniquet has been reported by the 
majority of workers. (See The Fibrinolytic System) 
Chen et al. (1982) found marked differences in platelet adhesive-
ness, thromboxane A2 and prostacyclin activity, between healthy 
subjects and patients with known ischaemic heart disease, after 
tourniquet application. Tourniquet application in healthy subjects 
induced a significant increase in prostacyclin generation; a simi-
lar increase was not seen in ischaemic heart disease patients, 
whereas both groups had increased thromboxane A2 levels. This 
finding suggests that patients with ischaemic heart disease may be 
more prone to developing platelet venous thromboses after a tourni-
quet application. This correlation has not been reported in the 
literature but could help to explain the reported differences in 
the incidence of deep vein thrombosis after tourniquet appli-
cation. 
An increase in prostacyclin and fibrinolytic activity, in non-
atherosclerotic subjects, would also help explain the findings of 
Romanus et al. (1978). Using intravital microscopy techniques, 
they found only one platelet thrombus after six hours' ischaemia in 
healthy medical students. 
c. 
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The No-Reflow HYJ>othesis 
The no-reflow phenomenon after tourniquet application was first 
hypothesised by Strock and Maj no (1969a). They studied rats who 
had had a tourniquet applied to a limb. Injecting carbon black 
into the tail vein at the release of the tourniquet, they demon-
strated that some vessels in the limb remained occluded for a con-
siderable period of time, even after a 15 minute tourniquet appli-
cation. After tourniquet times of 2t hours, only the major blood 
vessels were found to be patent immediately after tourniquet re-
lease. After a further two hours' "recovery", the carbon was de-
posited equally in both limbs, indicating the blood flow to the 
muscles of the ischaemic limb and control limb lolere the same. In a 
later article they listed thirteen possible causes for this tem-
porary, functional obstruction (Strock and Majno 1969) (Fig. 
2: 1). 
Miller et al. (1979) reported that the tissues distal to the tour-
niquet site were oedematous on removal of the tourniquet. This 
increase in tissue pressure may be involved in the "no-ref low phe-
nomenon" as Ashton (1975) reports that (1) Active closure of 
arterioles occur when transmural pressure is lowered, and (2) Pas-
sive collapse of capillary walls occurs when tissue pressure is 
greater than intraluminal pressure. 
FIGURE 2 . 1 
THE NO REFLOW HYPOTHESIS 
7 
2 
From: Strock and Majno .. 1969. 
From : Strock and Majno, 1969(b) 
(Publication Permission Applied For) 
1. Arteriolar spasm 
2 . Impaction of microemboli 
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3. Anoxic-ischaemic swelling of trapped white blood cells 
4. Alterations of endothelial surfaces causing stickiness 
S. Direct injury to endothelial cells with fragmentation, 
formation of gaps, loss of fluid and stasis 
6. Loss of fluid to perivascular cells 
7. Compression by swollen perivascular cells 
8. Endothelial swelling 
9. Collagen swelling constricting the vessel 
10 . Intramuscular blebs arising f rom the endothelium 
11. Formation of histamine leaks due to mast cell damage 
12. Formation of platelet thrombi 





It has been postulated that the no-reflow phenomenon may explain 
the delayed rise in CK activity in the venous blood after a two 
hour tourniquet time (Chiu et al. 1976, Heppenstall et al. 1979). 
Using this index, Chiu and co-workers ( 1976) suggest that the no-
reflow period lasts one hour after a two hour tourniquet time. 
Similarly, the delay in equilibration between the serum and inter-
stitial potassium levels may be partially explained by the no-re-
flow phenomenon (Jennische et al. 1982). This delay in equilibra-
tion took more than an hour after a three hour tourniquet applica-
tion to rabbit hind legs. 
Larsson and Bergstrom (1978) also described an apparent post-tour-
niquet no-ref low phenomenon in the muscles of rat limbs; the skin 
appearing to be less affected than skeletal muscles. 
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Summary of Vascular Changes 
The application of a tourniquet effectively prevents any blood 
flowing into the limb. Thus the blood remaining in the ischaemic 
limb is subjected to progressive hypoxia. This causes changes in 
the platelets, red blood cells and endothelium which renders throm-
bus formation more likely. The formation of platelet thrombi has 
not been clearly documented after tourniquet durations of up to 
three hours. However, many clotting parameters are species- and 
disease-specific so that pigs and patients with ischaemic heart 
disease may have an increased propensity to form platelet clumps 
after tourniquet ischaemia when compared with dogs or healthy 
patients. This, together with fibrinolytic changes, could explain 
the reported differences in the incidence of deep vein thromboses 
after operations under tourniquet. Any no-reflow phenomenon would 
also be more severe if platelet clotting is activated and this 
would prolong the duration of anoxia. 
Several mechanisms have been postulated to explain reactive 
hyperaemia which occurs after tourniquet release. Strock and Majno 
(1969b), however, maintain that some vessels supplying the tissue 
remain occluded for a period of time after tourniquet release; the 
occlusion time being proportional to the tourniquet duration. 
Oedema and tissue swelling are common in the hours after tourniquet 
release, the skin appearing to accumulate more water than the 
muscles. Post-operative tissue bleeding, caused by activation of 













been suggested as a potential cause of post-operative 
complications. 
2.7. SKIN TEMPERATURE CHANGES 
Skin temperatures have been measured by several authors (Sanders 
1973, Modig et al. 1978, Dery et al. 1965, Harris et al. 1975). 
They all note a tendency for the temperature of the ischaemic limb 
to fall towards room temperature during the tourniquet application. 
Some (Strock and Majno with rats, 1969a) recorded very rapid drops 
to a low plateau over the first hour. Others (Modig et al. with 
humans, 1978) recorded ·a more gradual decline in temperature, per-
haps an indication of the larger mass of the limb which has to 
equilbrate with the external temperature. As would be expected 
with actively metabolising tissue, the temperatur:e never drops to 
that of room temperature, even when the animals were studied in an 
incubator at 28°C (Strock and Majno 1969). 
On release of the tourniquet, the skin temperature rises rapidly to 
a plateau within four to eight minutes (Modig et al. 1978, Dery et 
al. 1965). In Modig and co-workers' report (1978), there was a 
tendency, not statistically significant, for the thigh and calf 
skin temperatures to exceed the pre-ischaemic levels. Sanders 
(1973) reported that the skin temperature of arms of patients who 
had undergone a one hour tou]\"niquet application, rose l.5°C above 
















In contrast, Strock and Majno (1969a) reported that the temperature 
of the ischaemic limb remained about 2°C lower than that of the 
control limb after release of a two hour tourniquet in rats. They 
postulated that this could be due to decreased cellular metabolism, 
increased heat loss by the oedematous tissue, decreased blood flow, 
or any combination of these. 
In summary, skin temperatures of the ischaemic limb have been shown 
to fall during tourniquet application. The different rates of fall 
may be due to the differing muscle masses of the animals studied. 
On release of the tourniquet, the skin temperature rapidly rises to 
pre-tourniquet levels. In some reports there is a tendency for 
this temperature to exceed pre-ischaemic levels, but this is not 
substantiated by others. Muscle temperatures do not appear to have 
been monitored in the tourniquet experiments described. 
2.8 COMPLICATIONS REPORTED WITH USE OF THE TOURNIQUET 
A. Neurological 
One of the major complications of tourniquet application is that of 
paralysis and paresis. The prevalence and possible mechanisms in-
volved have already been discussed. (Chapter 2.4) 
B. Systemic Complications 
Central Venous and Mean Arterial Pressure Changes 
Bradford (1969) measured a rise in central venous pressure (CVP) of 
some 17, 5 cm H20 if both legs were exsanguinated prior to the 
application of bilateral leg tourniquets. If one leg only was 
49 
exsanguinated, the rise was 9,7 cm H20· Without exsanguination, no 
change in central venous pressure occurred on application or re-
lease of the tourniquet. The auto-transfusion of 700 - 800 ml of 
blood from each leg on exsanguination is believed to cause these 
changes. With exsanguination and a tourniquet applied to one leg, 
the mean arterial pressure rose by 18,5 mmHg and on release it fell 
by 19,1 mmHg, due to changes in peripheral resistance. 
Care is necessary, therefore, when a limb tourniquet is applied to 
a patient who has mild congestive cardiac failure, in case auto-
transfusion causes a rapid rise in central venous pressure which 
could precipitate or exacerbate cardiac failure (Sanders 1973). 
This was perhaps the cause of the cardiac arrest shortly after the 
aplication of bilateral leg tourniquets reported in Middleton and 
Varian's survey (1974). 
Hyper t ension 
In a review of 600 patients who had had a tourniquet applied to a 
lower limb, Kaufman and Walts (1982) found that the incidence of 
induced hypertension was 11%. The probability of hypertension 
(defined as a 30% increase on pre-tourniquet blood pressure levels) 
was increased if the patient was elderly, had cardiac enlargement, 
or had a nitrous oxide or narcotic anaesthesia. By comparison, the 
incidence of hypertension in a control group of 100 patients under-
going hip surgery without a tourniquet was one percent. 
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Pulmonary microemboli 
Edfeldt and Thomson (1980) reported that, upon release of the thigh 
tourniquet in 26 patients operated upon for osteoarthrosis of the 
knee, cardiac output and -arterial P02 decreased, implying pulmonary 
microembolism. It was suggested that liberation of tissue thrombo-
plastins, causing aggregation of thrombocytes and trapping of 
fibrin, and not the release of particles of the acrylic monomer 
used with the prosthesis, caused these microemboli. These authors 
felt that pre-treatment with steroids could have a beneficial 
effect in preventing microemboli formation in patients with frac-
tures undergoing operat.ions under tourniquet. 
This is supported by the findings of Modig et al. (1978) who inves-
tigated pulmonary and circulatory changes in total hip replace-
ments, in which the potential risk of acrylic monomer microemboli-
zation was studied. Pre-treatment of patients with large doses of 
steroids (30 mg/Kg methylprednisolone) prevented the fall in car-
diac output and improved the leg and pulmonary blood flow. 
Pulmonary Embolism 
The incidence of deep vein thrombosis appears to be decreased by 
the use of the tourniquet (Chapter 2.5B). However, some patients 
who are to have tourniquets applied for reparative surgery have 
been immobilised in bed prior to their operations. These patients 
have a high potential for the development of a deep vein thrombosis 
during immobilization. Austin (1963) reported two cases and 
Estrera et al. (1982) one case who suffered from a pulmonary 
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embolism. These emboli were thought to be due to the dislodgement 
of a preformed clot from the femoral vein, during the application 
of an exsanguinating bandage. Although the patient of Estrera et 
al. (1982) was successfully resuscitated, the two patients reported 
by Austin (1963) died and at post mortem showed extensive ante-
mortem thrombi in the veins of the injured leg. These thrombi had 
been clinically silent at the time of surgery. 
Other Systemic Changes 
Other systemic effects occurring on release of the tourniquet, 
appear to be mild and · transient (Modig et al. 1978, Shaw-Wiglis 
1971, Klenerman et al. 1980, Hurst et al. 1981). 
C. ARTERIAL DAMAGE 
Plaque Disruption 
There is the possibility of disruption of an atheromatous plaque 
causing occlusion of the superficial femoral artery under the tour-
niquet. Thus Giannestras et al. (1977), suggest that an emergency 
arteriogram and perhaps arteriotomy, should be performed if the 
limb circulation does not return rapidly to normal after removal of 
a tourniquet. 
Aneurysm Formation 
Webb Jones (1955) and Scott (1955) reported aneurysms which occur-
red after foot operations, but they occurred secondary to unrecog-
nized trauma of the exsanguinated arteries. 
had had tourniquets applied to the thigh. 
All the above cases 
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Volkmann's Ischaemic Contracture 
Cases of Volkmann's ischaemic contracture and even gangrene due to 
"arterial spasm" have been described after the use of Esmarch' s 
bandages and solid rubber bands as tourniquets (Wallis 1901, 
Griffiths 1950, Watson-Jones 1952). Barnes and Trueta (1942) were 
able to produce long-standing arterial spasm in rabbits when they 
used tourniquets consisting of a soft wire encased in rubber 
tubing. With soft tubing alone, this spasm did not occur. Today, 
Volkmann' s ischaemic contracture is more likely to occur when too 
tight a dressing or plaster is applied to a limb, or when there is 
marked swelling after t ·ourniquet release. 
The Post-ischaemic Hand Syndrome 
The post-ischaemic hand syndrome of oedema, colour changes, paras-
thesia and weakness, occurs particularly in subjects who have an 
impaired circulation prior to tourniquet application (Tubiana 
1973). 
D. COMPLICATIONS ASSOCIATED WITH SPECIFIC DISEASES 
Monckeberg's Calcinosis 
Calcification of the arteries, in a reported case of Monckeberg 's 
calcinosis, caused the tourniquet to act as a venous tourniquet as 
the artery could not be occluded. Hence, when the tourniquet was 
pressurised, the bleeding at the operative site actually increased 
(Jeyaseelan 1981). 
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Sickle Cell Disease 
An estimated 8 - 14% of the American Black population have sickle 
cell haemoglobinopathy and are prone to undergo sickling, throm-
boses and tissue infarction if subjected to hypoxia. These are 
theoretical reasons why .tourniquets are avoided in this population 
group. Stein and Urbaniak (1980) undertook a 17-year review of 
tourniquet procedures which involved 29 tourniquet applications to 
21 patients with sickle cell disease. They found no differences 
between the incidence of complications in the sickle cell patients 
and that in a randomly selected normal control population. They 
concluded that the use of the tourniquet was not contra-indicated 
in patients with sickle cell disease. 
E. OEDEMA 
Swelling of the hand occurs within ten minutes of the release of an 
arm tourniquet under normothermic conditions (Paletta et al. 1961). 
It is usually maximum at two hours and persists for up to a week 
(Lundborg 1970). The oedema appears even after a tourniquet time 
as short as one hour (Stock et al. 1971, Heppenstall et al. 1979) 
and can seriously hinder tissue healing. To minimise the swelling, 
Sanders (1973) recommends elevation of the upper limb for at least 
five days after surgery using the tourniquet. 
Miller and co-workers (1979) suggested that post-tourniquet oedema 
was the cause of the significantly higher pressures measured in 
both the vastus lateralis and anterior tibial muscles of primates 
24 hours after a 2~ hour tourniquet. They noted that this pressure 
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rise may cause compartmental syndromes in those muscle groups 
bounded by rigid fascia! sheaths. 
Larsson and Bergstrom (1978) showed that the increase in total 
muscle water which occurred within one minute of tourniquet release 
was mainly due to increased extracellular water. Morphological 
studies by several authors (Harman 1947, Heppenstall et al. 1979, 
Solonen and Hjelt 1968, J'osza et al. 1980) confirmed this. 
F. TOURNIQUET SHOCK 
Tourniquet shock, caused by the release of a very prolonged tourni-
quet application, is a well described entity (Stock and Isselhard 
1972, Stock et al. 1975, Kristen et al. 1970, Schubert et al. 
1976). The removal of a five hour tourniquet from the hind limb of 
dogs caused an immediate fall in blood pressure, and led to renal 
failure (Stock and Isselhard 1972). These authors suggested that 
circulatory collapse was caused by the marked vasodilation and 
oedema in the ischaemic limb due, in part, to ATP depletion in the 
smooth muscle of the blood vessels. Kirsten and co-workers (1970) 
suggested that the profound release of potassium from the damaged 
muscle cells after tourniquet release was the probable cause of 
early cardiac arrest in many of the dogs. 
G. OTHER COMPLICATIONS 
Using a retrospective questionnaire study completed by 151 respon-
ding orthopaedic surgeons, Middleton and Varian (1974) reported the 
following complications associated with the use of a tourniquet : 
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one case of full thickness burns from a 'hot' tourniquet; one femo-
ral artery 'spasm' with full recovery; two cases of post-operative 
intermittent claudication, one of which required by-pass surgery; 
one case of Volkmann's ischaemic contracture, and one case of sud-
den cardiac arrest after bilateral leg exsanguination. 
Flatt (1972) reported the case of a full circumferential burn 
caused by the alcohol skin cleaning solution soaking the tourni-
quet. 
SUMMARY OF AND RECOMMENDED PRECAUTIONS TO DECREASE THE CLINICAL 
COMPLICATIONS ASSOCIATED ·wrTH .TOURNIQUET USE 
Many complications of tourniquet application are listed in the 
literature. Some, such as dislodgement of an atheromatous plaque, 
or aneurysm formation, are extremely rare. Others, such as an 
increase in mean arterial and central venous pressures, occur fre-
quently with limb exsanguination prior to tourniquet application. 
Swelling of the limb due to oedema or vascular insufficiency, after 
tourniquet release, can lead to the serious complications of post-
ischaemic hand syndrome or Volkmann's ischaemic contracture. 
In order to reduce the frequency of some of the complications, 
various recommendations have been made: 
Logel (1976) reported a case of a rupture of the long tendon of 
biceps brachi muscle after an operation utilising an arm tourni-
quet. However, other factors, such as rheumatoid arthritis and 
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local corticosteroid injections, also probably accounted for a 
decrease in tensile strength of the tendon and these, together with 
the ischaemia and pressure created by the tourniquet, led to the 
tendon's subsequent rupture. 
(a) The Patiertt 
Klenerman (1982) has recommended that, prior to the use of an above 
knee tourniquet, especially in elderly patients, the state of the 
skin and nails and presence of hair in the limb should be noted. 
One pedal pulse, preferably the posterior tibial, should be pal-
pable. Radiographs of ·the knee should also be checked for evidence 
of calcification of the vessels. Patients who have anaemia, hypo-
volaemia, metabolic acidosis or pre-existing cardiovascular disease 
have a reduced buffering capacity. Thus, special care should be 
taken with these patients because of the risk of sudden cardiac 
collapse on removal of the tourniquet. Care should also be taken 
to avoid using a tourniquet on subjects who may already have a deep 
vein thrombosis because of the risk of pulmonary embolus. 
Klenerman (1982) and Rorabeck (1980) recommend that the shape and 
size of the patient's limb be taken into account when estimating 
the tourniquet pressure to be applied. 
(b) The Equipment 
The automatic tourniquet apparatus should be checked regularly for 
accuracy and stability (Chapter 5.5). 
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Additional towelling should be placed over the tourniquet to mop up 
any excess skin preparation fluid. The towel should be removed 
prior to inflation of the cuff (Flatt 1972). 
(c) Patient After-care 
If possible, the upper limb should be elevated for at least five 
days after surgery under tourniquet (Sanders 1973). Dressings and 
plaster should be sufficiently loose to allow for post-operative 
limb swelling. The dressings should be carefully checked for 
tightness in the early post-operative period in order to prevent 
ischaemic damage to the tissues. 
2. 9 OVERALL SUMMARY AND CONCLUSIONS ON THE EFFECTS OF TOURNIQUET 
APPLICATION 
In a general way, the following can be said: 
Although the tourniquet has been used for several centuries, the 
pneumatic tourniquet only came into clinical use in 1904. Since 
then it has been used extensively in various limb operations for 
which the surgeon requires a bloodless field. However, there is 
still much debate as to the amount of damage caused by its applica-
tion and its safe pressure or duration. Although morphological 
damage to skeletal muscle appears to be minimal in the first hour 
of tourniquet application, capillary endothelial damage and oedema 
occurs within the first 30 minutes. 
Neurological tissue appears to be much more sensitive to the shear 
forces exerted under the edge of a tourniquet than to ischaemia or 
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direct pressure alone. The high reported incidence of electromyo-
graphically proven partial denervation of the skeletal muscles 
after tourniquet application has important implications for the 
sportsman undergoing surgery. Full rehabilitation of a muscle 
which has a defective nerve supply will never be achieved until the 
nerve has regenerated, a process which may take three to six 
months. Thus, in future, the injured sportsman wishing to return 
to his sport as soon as possible may well be advised to ask the 
surgeon to avoid the use of the tourniquet, if at all possible. 
The metabolic effects of anoxia are pronounced within 30 - 60 
minutes of tourniquet ischaemia and increase with the duration of 
its application. The exhaustion of energy-rich phosphate stores 
occurs after about three hours of tourniquet application, after 
which time the various metabolic and energy requiring cycles of the 
tissue cells begin to fail. It would thus seem that prolonging the 
tourniquet duration longer than three hours would severely damage 
the integrity of the ischaemic tissue. One way of preventing the 
total exhaustion of adenosine triphosphate is to release the cuff 
for 10 - 15 minutes every hour. Another way would be to attempt to 
slow the cells' metabolic rate during the ischaemic period. 
The reactive hyperaemia after tourniquet release has long been 
recognised. However, it appears that, after two hours' tourniquet, 
a no-reflow phenomenon may occur. This implies that certain areas, 
distal to the tourniquet, may remain ischaemic and, therefore, 
liable to continued damage for up to an hour after release of a two 
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hour tourniquet. Whether this is due to temporary platelet plug-
ging because of increased platelet aggregation or whether it is a 
purely functional cause, has not been elucidated. Also unclear is 
whether or not the application of a tourniquet causes an increased 
or decreased risk of deep vein thromboses. 
Thus, whilst the complications of the actual procedure are for-
midable, some of the precautions to decrease them in clinical prac-
tice are relatively straightforward. I believe that the use of the 
tourniquet can be made safer if the surgical team is made aware of 
its problems and can le.arn to avoid them. 
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CHAPTER THREE 
A REVIEW OF THE LITERATURE ON THE EFFECTS AND USE OF 
LOCAL AND WHOLE BODY HYPOTHERMIA 
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3.1 HISTORICAL BACKGROUND 
The use of cold as a therapeutic modality has its origins in antiquity. 
Hippocrates used cold application in 300 B.C. and noted that it de-
creased swelling and reduced pain by producing numbness. In 1661 Thomas 
Bartolin wrote a treatise on the medical uses of snow in leg resections, 
ulcer cautery and perinea! lithotomy incisions for bladder stones. 
Larrey, chief surgeon to Napoleon, used refrigeration anaesthesia for 
amputations on the Russian Front in 1813 (McMaster 1982). 
Total body hypothermia was described in 1862 by Walther who reported the 
effects of cooling rabbits to 20°C. Smith and Fay (1940) produced body 
temperatures of 29 - 35°C for four to five days in the treatment of 
cancer patients. In 1950, Bigelow and co-workers in Canada reported the 
first use of hypothermia during cardiac surgery. Since that time the 
use of hypothermia, by extracorporeal blood cooling, has continued to 
play an important role in open heart surgery, as well as in certain 
neurological operations. Various workers have also reported the protec-
tive effect of hypothermia in experimentally induced haemorrhagic shock 
(Postel et al. 1957, Stock et al. 1975, Haljamae et al. 1970, Hagberg et 
al. 1970). 
3.2 THE PHYSIOLOGICAL AND BIOCHEMICAL EFFECTS OF HYPOTHERMIA 
Most of the physiological and biochemical effects of hypothermia have 
been described for total body hypothermia. Andjus and co-workers (1956) 
succeeded in cooling rats to 0°C and below. The lowest temperature they 
obtained, with subsequent survival, was -5°C and this temperature was 
maintained for as long as 70 minutes. This suggests that the 
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achievement of almost zero oxygen consumption with recovery is possible 
in warm-blooded animals. 
A. Tissue Oxygen Consumption 
Oxygen uptake decreases as temperature falls (Abrahamson et al 
1958) although, as Gray and Nunn (1980) point out, this does not 
necessarily indicate a lowered oxygen requirement. There is a 
leftward shift of the haemoglobin dissociation curve so that oxygen 
is less easily released to the tissues. This shift, however, may 
not affect oxygen utilisation by the tissues because of increased 
oxygen solubility at low temperatures (Lundsgaard-Hansen 1966). 
B. Blood Acid Base Balance 
The acid base balance appears to be relatively unaffected by hypo-
thermia, provided no crisis occurred on rewarming, and there was no 
passive congestion (Lundsgaard-Hansen 1966). If either occurred, a 
metabolic accidosis results. All pH readings taken at a low body 
temperature must be corrected to that body temperature if the pH 
meter has been calibrated to read at 37°C. 
C. Basal Metabolic Rate 
Basal metabolic rate falls with the fall in body temperature, if 
shivering is prevented. Some animal studies have suggested that, 
when the body temperature falls below 10 - 15°C, metabolism has 
essentially stopped (Lynn et al. 1954). This has been disputed by 
others who believe cellular metabolism persists even at these low 
temperatures (Benazon 1960). 
63 
D. Tissue Carbohydrate Metabolism 
Hypothermia is believed to interfere with the enzymes regulating 
glucose metabolism (Wynn 1956). Blood glucose rises due to de-
creased insulin release and reduced liver glucose uptake. This 
mild degree of hyperglycaemia may cause a degree of cellular dehy-
dration (Wynn 1956). 
E. Changes in Blood Flow, Blood Viscosity and Blood Coagulability 
Blood flow decreased slightly in a limb immersed in a water bath at 
13 - 15°C for two hours, although the reduction in flow was only 
conspicuous during the first 15 minutes (Barcroft and Edholm 
1943). 
F. 
Blood viscosity increases as the temperature falls and sludging in 
the capillaries may occur. There is thrombocytopaenia, haemocon-
centration and a reduction in the eosinophil and leucocyte counts. 
The coagulation processes are also markedly slowed and, during 
prolonged cooling, there is a progressive loss of fibrinogen due to 
the release of fibrinolysins (Gray and Nunn 1980). This has led to 
occasional bleeding problems during extracorporeal blood cooling 
used in cardiac by-pass surgery. 
Serum Electrolyte Changes 
With whole body cooling in normovolaemic patients and animals, 
there is a significant rise in serum potassium. This is further 
increased if a metabolic acidosis occurs or if there is an infusion 
of stored blood (Wylie and Churchill-Davidson, 1972). 
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Hypothermia has been shown to influence serum potassium levels 
after haemorrhagic shock. HaljamaE! (1970) and Hagberg et al. 
(1970) showed that when haemorrhagic shock developed under normo-
thermic conditions, the potassium content of the cells was markedly 
lowered and no active cellular potassium reaccumulation was seen. 
However, when haemorrhagic shock was treated with hypothermia, the 
initial intracellular potassium loss was less, and active re-accu-
mulation occurred during recovery (HaljamaE!, 1970). In these 
animals there was also only a moderate increase in the potassium 
content of the local tissue fluid and only a slight increase in 
plasma potassium concentrations. The corresponding changes in the 
normothermic, shocked animals were much greater. 
G. Neuromuscular Function Effects 
Muscle cooling below 20°C delays twitch time and the tension pro-
duced during muscular contraction. Neuromuscular transmission at 
the end plate is decreased below 15 °C and totally blocked at 5 °C. 
However, motor end plate potentials are shown to persist down to 
l°C (McMaster 1982). 
3.3 LOCAL HYPOTHERMIA AND TOURNIQUET APPLICATION 
There are very few studies of the use of hypothermia during tourniquet 
application. 
Paletta et al. (1961) cooled the limbs of dogs prior to and during tour-
niquet application. When compared to the normothermic limbs, there was 
less histological damage, a more rapid hyperaemia and the suggestion of 
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an increased blood flow in the cooled limbs after tourniquet release. 
Shehardi et al. (1961) also reported that hypothermia reduced post-
operative tourniquet paralysis and oedema in dogs. 
The immersion of rats' tails in water at 0°C, during the application of 
a two hour tail tourniquet, inhibited the extent of the subsequent 
swelling, both during the early period and during the first week after 
tourniquet removal (Rosenthal and Thornton, 1970). Exposure of the tail 
to 37°C during this period caused a marked and prolonged swelling; tail 
volume increasing over a period of 15 days to 163% of the original. 
Cooling or warming of the tail (0°and 15°C) after tourniquet removal had 
no significant effect upon the course of the swelling. 
Nakahara and Sakahasi ,(1967) found a marked decrease in the post tourni-
quet bleeding tendency in an experiment where the limb was cooled by 
10°C prior to tourniquet application. They also presented four cases in 
which pre-cooling of the lower limbs by 10°C before tourniquet applica-
tion resulted in a consistent decrease in post-operative complications. 
A similar technique was reported by Seki ( 1980) who cooled the forearm 
with ice bags for 30 minutes after induction of general anaesthesia and 
before tourniquet application. In 12 cases in whom a tourniquet was 
kept inflated for an average of 3\ hours (maximum time : 4 hours, 7 
minutes), the only complications were temporary dysaesthesia at the 
finger tips in two cases and a tingling in the fingers when the wrist 
was tapped (Tinnel's sign) in another. The same author also performed 
an experimental study on 35 dogs in which tourniquets were applied for 
five hours after 
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the limb had been cooled from 38°C to 16 -18°C by immersion in ice. 
Oedema was reported to subside much faster in the cooled group, who also 
stopped limping faster than did the control group. 
3.4 CONTRA-INDICATIONS TO THE USE OF HYPOTHERMIA 
Patients in whom the use of hypothermia may be contra-indicated are 
those susceptible to cold-induced injury. Subjects with collagen dis-
eases such as lupus erythematosis and rheumatoid arthritis may develop 
severe vascular spasm on cold exposure. Some patients exhibit a cold 
allergy caused by cold agglutinins and some develop cryoglobinuria or 
haemoglobinuria on cold exposure. Thus patients with an impaired peri-
pheral circulation require careful assessment before the additional 
insult of hypothermia is considered. 
3.5 SUMMARY AND CONCLUSION ON THE EFFECTS AND USE OF HYPOTHERMIA 
Most of the physiological and biochemical changes that occur during 
hypothermia have been reported for whole body cooling of animals and 
humans. Hypothermia has been found to protect the body tissues and 
organs when the normal circulation is interrupted, as during cardiac 
surgery or in haemorrhagic shock. Some workers described the local use 
of hypothermia and tourniquets in dog experiments in the 1960s (Paletta 
et al. 1961, Shehadi et al. 1961) and recently a Japanese surgeon (Seki, 
1980) has described the successful 'safe' prolongation of an upper arm 
tourniquet by hypothermia application. All these workers used ice and 
cooled the limbs for varying periods prior to tourniquet application. 
Little or no quantitative data were presented to establish a protective 
effect of hypothermia on muscles and nerves subjected to tourniquet 
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ischaemia. Furthermore, there appear to be practical problems associ-
ated with the application of local hypothermia as described. 
include 
These 
1. The use of water-ice bags which could create practical problems 
in a busy theatre. 
2. The prolongation of the anaesthetic time by up to 30 minutes 
whilst the limb is cooled prior to tourniquet application • . 
3. The difficulty of cooling a well-perfused limb by 10°C, without 
causing marked body core cooling, must be considered. This is 
especially relevant in the post-operative recovery stage when 
marked shivering can increase a patient's oxygen requirements 
severalfold (Gray and Nunn 1980). 
It is clear that further studies are required to determine the role of 




THE PROTECTIVE ROLE OF HYPOTHERMIA IN TOURNIQUET- INDUCED 
MUSCLE ISCHAEMIA: AN EXPERIMENTAL STUDY 
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4.1 INTRODUCTION 
On the basis of the studies reviewed in Chapters 2 and 3, I decided to 
examine the protective role of hypothermia in muscles made ischaemic by 
the application of a tourniquet. 
Landrace pigs were chosen as an experimental model because their fore-
limb muscles, like those of man, are of mixed type I (slow twitch) and 
type II (fast twitch) fibres. Other experimental animals have muscles 
which contain predominantly type I or type II fibres only. Thus the 
mixed muscles of pigs may behave in a similar fashion to those of man. 
A commercially available cold gel enclosed in specially constructed 
plastic bags which could be wrapped closely around the limb, was used. 
This method of creating local hypothermia for tourniquet ischaemia has 
not been described before, but it appears to have the advantages of easy 
to apply, non-messy, re-usable and, as will be found, creates a cooling 
effect in the limb which lasts for at least three hours. It can also be 
applied to the area directly under the tourniquet where most neuromuscu-
lar damage is expected to occur. Thus, it was possible to apply the 
cooling immediately prior to the tourniquet application, not for half an 
hour prior to the procedure, as described by other authors (Paletta et 
al. 1961, Shehadi et al. 1961, Nakahara and Sakahasi 1967, Seki 1980). 
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4.2 MATERIALS AND METHODS 
A. Equipment: 
For producing hypothermia 
A thermolabile polyglycol gel enclosed in clear plastic bags (Kay 
Laboratories, U.S.A.) was used to wrap around the limbs. A sealed 
soft rubber tube was also filled with the gel and wrapped around 
the limb directly under the site for the tourniquet application. 
These bags had previously been kept for at least 12 hours in the 
deep freeze, the gel remains in a soft state even when frozen. 
To insulate the ice bags and to ensure they remained cold for the 
duration of the procedure, a sleeve of 2,5 mm thick Neoprene 
material (closed cell construction) was placed over the ice bags. 
For Temperature ~asurements 
Intramuscular and skin temperatures were measured in both limbs 
using thermocouple probes connected to Ellab Instruments, Type TE.3 
thermometers (Electrolaboratoriet, Copenhagen). The ice bag tem-
peratures were monitored by a direct reading thermocouple connected 
to an oscillograph 400 MD/2 (George Washington Ltd., England). The 
nasal temperatures were monitored using a nasal/rectal thermometer 
(Yellow Springs Instrument Co. Ltd.). To prevent the skin probes 
monitoring the ice bag and not the skin temperature, pieces of 
neoprene were taped between the probes and the ice bags. All the 
temperature probes were calibrated and checked against each other 
before each experiment. 
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For Pressure Measurements 
A LX0503A pressure transducer, measuring pressure in mmHg with a 
stable pressure range of up to 1520 mmHg was placed in circuit with 
an Intersil ICL7016 Evaluation Kit digital readout display. The 
components were placed in a Rose enclosure (Cat. 912208) and DC 
power was provided by a PPZ battery. The transducer was periodi-
cally checked and re-calibrated if necessary against a mercury 
manometer. 
B. PROTOCOL FOR THE NORMOTHERMIC GROUP (16 Pigs) 
1. Land race pigs, 18 - 25 Kg, were anaesthetised with pentothal, 
intubated and ventilated with a nitrous oxide, oxygen mixture. 
2. For maintenance of anaesthesia, pentothal supplementation and 
N20: 02 was used. Halo thane was avoided because of the risk of 
provoking malignant hyperthermia, to which this particular 
breed of pig is susceptible (Woolf et al. 1970). 
3. Using sterile techniques, catheters were inserted into the 
carotid artery and internal jugular vein in the neck. The 
arterial line was used for blood pressure monitoring and blood 
sampling. The venous line was used for intravenous fluid main-
tenance during the procedure, at a rate of approximately 4. 5 
ml/Kg/hr. 
4. For the measurement of effluent venous blood, a 16 gauge cathe-
ter was inserted into an ante cubital fossa vein of the fore-
limb, proximal to the tourniquet. 
5. After iodine preparation of the skin, an open muscle biopsy was 












to be applied. All muscle biopsies of the ischaemic limb were 
taken from sites which had been under the tourniquet. The biop-
sy was divided into five parts of between 80 - 150 mg each, 
placed in Greiner tubes, stoppered and placed immediately in 
liquid nitrogen. The time delay from taking the biopsy to the 
last sample being placed in liquid nitrogen was less than 60 
seconds. All biopsies were stored in liquid nitgrogen until 
analysed within a week for glycogen content and phosphofructo-
kinase activity. 
Ethicon sutures. 
The biopsy wounds were closed with 4,0 
6. A 5 cm wide Kidde pneumatic tourniquet cuff was then applied to 
the limb and inflated to 500 mm Hg pressure for three hours. 
The pressure was checked using the digital read-out pressure 
transducer. 
7. Prior to, during and after the three hours' tourniquet applica-
tion, blood samples were drawn and temperatures measured (4.2 
D and E). 
8. After three hours the tourniquet was removed and after ten 
minutes another muscle biopsy taken, using the technique de-
scribed in 5 (above). 
9. The pig was given 1 million units' penicillin intravenously 
during the procedure and 200,000 units intravenously daily for 
four days after the procedure. 
10. The pig was then monitored for a further three hours before the 
limb line was removed, the central line strapped in place, and 
the pig returned to its cage. 
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mation of serum creatine kinase activity. 
12. On the sixth day, the pig was re-anaesthetised and subjected to 
a further two hours' tourniquet ischaemia to the same limb. 
Muscle biopsies and other measurements, w1 th the exception of 
temperatures and blood lac tat es, were taken as previously. A 
muscle biopsy was also taken from the corresponding muscle in 
the control limb. 
13. Daily blood samples were taken for estimation of creatine 
kinase activity for a further four days. Biopsy samples were 
taken from the muscle of the tourniquet limb and the control 
limb of the anaesthetised pig just prior to administration of 
a pentothal overdose, on the tenth day after the initial 
surgery. 
14. Each set of muscle biopsies was taken from the same muscle 
before and after the tourniquet, but from a muscle which had 
not been previously damaged by biopsy. Thus, w1 th the first 
tourniquet, the biopsy was taken from muscle one; with the 
second tourniquet from muscle two and, at sacrifice, from 
muscle three. Muscles two and three were also biopsied on the 
control limb at days six and ten respectively. 
15. If the pig was seen to be 111, or if the site of the indwelling 
catheters became infected, the pig was re-anaesthetised. 
Muscle biopsies were taken from the tourniquet and control 




PROTOCOL FOR THE HYPOTHERMIC GROUP (11 Pigs) 
1. Landrace pigs, 18 - 25 Kg were anaesthetised with pentothal and 
ventilated with a nitrous oxide, oxygen mixture. 
2. A forelimb was prepared with iodine, a muscle biopsy taken and 
the tourniquet applied at 500 mmHg pressure for 3 hours. 
3. Hypothermia was produced by encasing the limb, including the 
area under the tourniquet cuff, with bags containing the cold 
polyglycol gel. Hypothermia was also produced in the control 
limb by wrapping it with the cold gel bags. 
4. To prolong the cold period, a further cover of insulating neo-
prene was placed over both hypothermic limbs and bags. 
5. The remainder of the protocol and the measurements made were 
the same as for the normothermia group. 
D. SYSTEMIC AND PERIPHERAL BLOOD MEASUREMENTS 
Measurements of creatine kinase activity, lactate, potassium and 
calcium levels and pH 
Blood samples for estimation of serum creatine kinase activity and 
lactate levels were taken from the central line prior to the 
tourniquet application and then at hourly intervals until the 
tourniquet was removed. Immediately on removal of the tourniquet, 
and at 5, 10, 15, 20, 30, 60, 120 and 180 minutes after tourniquet 
release further blood samples were taken from both the central and 
the peripheral lines. 
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Blood samples for pH, potassium and calcium levels were taken from 
the central line prior to and one hour after commencement of the 
tourniquet. Immediately on release of the tourniquet and at five 
minute intervals until 20 minutes had elapsed further blood samples 
were taken from both the . central and peripheral lines. 
For the next six days, blood was taken daily from the indwelling 
central line for estimation of creatine kinase activity. Measure-
ments taken on day six during tourniquet re-application were simi-
lar except no limb lines were inserted. Blood was drawn from the 
central line prior to the general anaesthetic, during the two hour 
tourniquet time, and at 5, 10, 15, 20, 30 60 and 180 minutes after 
tourniquet release. 
For the next four days, daily blood samples were drawn daily from 
the indwelling central line for estimation of creatine kinase 
activity. 
E. SKIN, MUSCLE AND NASAL TEMPERATURE MEASUREMENTS 
The nasal, intramuscular and skin temperatures of both the tourni-
quet and the control limbs were recorded every five minutes from 
immediately before, and for 30 minutes after tourniquet applica-
tion. Thereafter temperatures were recorded at 45, 60, 90, 120, 
150 and 180 minutes. 
On release of the tourniquet, the temperatures were recorded every 
two minutes for 10 minutes, then every 5 minutes until 30 mintes 
and, thereafter at 45, 60, 90, 120, 150 and 180 minutes. 
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4.3 STATISTICAL METHODS USED 
The raw data were analysed, using two-way and three-way Analysis of 
Variance (ANOVA) techniques. Acceptance intervals of the mean were used 
to determine significance at p < 0,05 levels. 
4.4. EXPERIMENTAL RESULTS 
A. During the Tourniquet Application 
Metabolic and biochemical parameters 
There were no significant differences in serum creatine kinase 
activity, pH, potassium, or sodium levels between the hypothermic 
and normothermic groups during the three hours of tourniquet appli-
cation. (Table 4.1) 
TABLE 4:1 METABOLIC AND BIOCHEMICAL PARAMETERS DURING THE TOURNIQUET 
Parameter measured HYPOTHERMIC NORMOTHERMIC 
during tourniquet application GROUP GROUP 
n=lO n=ll 
Mean s.o. Mean S.D. 
Creatine kinase (CK) IU/L 160,00 110, 80 310,00 225,00 
Lactate (central) mole/m 0,94 0,33 1,41 0,65 
Hydrogen Ion concentration (pH) 7,52 0,08 7,57 0,07 
Potassium (K+) mmole/L 3,95 0,46 3,70 0,19 
Sodium (Na+) mmole/L 131,20 2,80 136,70 3,60 
Values expressed as means + S.D. There were no significant 
differences between any values in the two groups. 
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Central, Muscle and Skin Temperatures 
Apart from the first central (nasal) temperature prior to tourni-
quet application, there was no significant difference between the 
central (nasal) temperature of the hypothermic and normothermic 
groups. (Table 4.2) 
TABLE 4.2 CENTRAL TEMPERATIJRES (°C) DURING TOURNIQUET APPLICATION 
Duration of tourniquet NORMOTHERMIC GROUP HYPO THERM IC GROUP 
application n = 11 n = 10 
(minutes) 
PRE 37,0 0,52 38,0 1 * 
5 37,4 0,58 38,2 0,91 
10 37,5 0,62 38,3 0,80 
15 37,5 0,67 38,2 0,85 
20 37,5 0,65 38,2 0,88 
25 37,5 0,64 38,1 0,90 
30 37,5 0,65 38 ,2 0,88 
35 37,6 0,69 38,0 0,86 
40 37,6 0,71 38,0 0,86 
45 37,7 0,75 37,9 0,87 
60 37,9 0,92 37,9 0,95 
90 38,4 1.04 37,9 0,84 
120 38,6 1,07 37, 9 0,81 
150 38,8 1,13 38,0 0,97 
180 38,6 1,02 38,2 0,99 
* P < O, 05 
Values expressed as means±:_ S.D. 
The muscle temperature of the ischaemic limb of the normothermic 
group fell progressively until about 90 minutes after tourniquet 
application, at which time it levelled off (Figure 1). The control 
limb muscle temperature of the normothermic group rose gradually 
during the tourniquet application following the similar gradual 
rise in the central temperature. (Table 4.2) 
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The muscle temperature of the ischaemic limb of the hypothermic 
group showed a rapid fall to very low levels (+16°C) over the first 
45 - 60 minutes and then levelled off for a further 30 minutes. 
Thereafter it rose gradually (Figure 2). After three hours' tour-
niquet application the muscle temperature remained significantly 
lower (p < O, 0001) than the ischaemic limb of the normothermic 
group. The temperature of the hypothermic control limb muscle fell 
almost as rapidly as that of the ischaemic limb, reaching a minimum 
at about 40 minutes. Thereafter, the muscle temperature rose, 
although after three hours it was still significantly (p < 0,01) 
lower than its temperature had been prior to cooling. 
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MUSCLE TEMPERATURES DURING TOURNIQUET 
NORMOTHERMIC GROUP. 
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FIGURE 1 NORMOfHERMIC GROUP 
Note the progressive fall in muscle temperature of the 
ischaemic limb for 90 minutes. The control limb muscle temp-
erature rises gradually during the three hours of tourniquet 
application. 
Results expressed as mean for 11 experiments, with no S.D. difference 
between the~-
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FIGURE 2 HYPOfHERMIC GROUP 
Note the rapid fall in muscle temperature of both the ischae-
mic and control limbs and the subsequent gradual rise. 
Results expressed as mean for 10 experiments. 
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The skin temperature of the ischaemic limb of the normothermic 
group fell steadily during the three hours' tourniquet application. 
The skin temperature of the control limb of the normothermic group 
rose gradually following the slow rise in the nasal and muscle 
temperatures. (Figure 3) 
The skin temperature of the ischaemic limb of the hypothermic group 
fell rapidly during the first two hours' tourniquet, reaching a 
minimum temperature of +9°C. The temperature then rose 3°C during 
the final hour of tourniquet application. The skin temperature of 
the control limb of the hypothermic group also fell, reaching a 
minimum value of +26°C after about 40 minutes and thereafter 
gradually rising. At the end of the experiment, the skin of the 
control limb in the hypothermic group was still significantly 
cooler (p < 0,01) than at the start of the experiment (Figure 4). 
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FIGURE 3 NORMITTHERMIC GROUP 
Note the progressive fall in skin temperature of the ischae-
mic limb and the slow rise in skin temperature of the control 
limb. 
Results expressed as mean for 11 experiments,with no S.D. difference 
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FIGURE 4 HYPITTHERMIC GROUP 
Note the rapid fall in s kin temperatures of both the ischae-
mic and control limbs and the subsequent gradual rise. 
Results expressed as mean for 10 experiments. 
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B. AFTER TOURNIQUET RELEASE 
Serum Lactate Levels 9-Jmole/ml) 
Values measured in the carotid artery: central levels 
There was no significant difference in serum lactate levels between 
the hypothermic and normothermic groups until two hours after 
tourniquet release. The lactate levels in the normothermic group 
then rose significantly above the levels in the hypothermic group 
(Figure 5). 
Values measured in the ante cubital vein of the tourniquet limb 
peripheral levels 
Peripheral lactate levels were significantly higher in the normo-
thermic group for the first 15 minutes, and again between two and 
three hours after tourniquet release. (Figure 6) 
CENTRAL LACTATE LEVELS AFTER TOURNIQUET 
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FIGURE 5 CENTRAL LACTATE LEVELS MEASURED IN A CAROTID 
ARTERY 
Note the significant elevation of the carotid artery lactate 
levels in the normothermic group 120 and 180 minutes after 
tourniquet release. 
Results expressed as mean for 10 experiments in each group 
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FIGURE 6 PERIPHERAL LACTATE LEVELS MEASURED IN AN ANTE-
CUBITAL VEIN 
Note the significant elevation of venous lactate levels in 
the normothermic group for 15 minutes after tourniquet 
release, and again at 120 and 180 minutes. 
Results expressed as mean for 10 experiments in each group 
with acceptance intervals of the mean at 1, 5, 10, 15, 120 
and 180 minutes. 
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Blood pH 
The venous blood pH was significantly higher in the hypothermic 
group on release of the tourniquet and had returned to baseline 
levels within five minutes of tourniquet release. In contrast, pH 
of the normothermic group had not returned to baseline levels even 
15 minutes after tourniquet release (Figure 7). 
The arterial pH measured in the carotid artery remained stable 
during the tourniquet application and did not alter with its 
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FIGURE 7 
Note the significantly lower venous pH in the normothermic 
group and the slow return to baseline. 
Results expressed as mean for 8 experiments in each group 
with acceptance intervals of the mean to baseline values at 
1, 5 and 10 minutes. 
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Serum Potassium Levels (mmole /litre) 
peripheral vein of the ischaemic ·ttmb 
Measured in the 
On release of the tourniquet there was a significant rise in serum 
potassium levels in the effluent venous blood of both the 
hypothermic and normothermic groups. However, potassium levels of 
the hypothermic group returned to baseline levels within 10 
minutes, whereas the potassium levels of the normothermic group 
were still significantly raised 20 minutes after tourniquet 
release. (Figure 8) 
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FIGURE 8 
Note the significant elevation of the serum potassium of the 
normothermic group and its continued elevation above baseline 
levels, even 20 minutes after tourniquet release. 
Results expressed as mean for 9 experiments in each group. 
Acceptance intervals of the mean are included at 10, 15 and 
20 minutes. 
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Serum Calcium Levels (mmole/litre) 
There were no significant differences in serum calcium levels 
between the hypothermic and normothermic groups, nor was there any 
significant change with time. (Table 4.3) 
Serum Sodium Levels (mmole/litre) 
There were no significant differences in serum sodium levels 
between the hypothermic and normothermic groups. (Table 4.3) 
TABLE 4.3 SERUM SODIUM AND CALCIUM LEVELS (mmole/litre) 
Time after tourniquet HYPOTHERMIC GROUP NORMOTHERMIC GROUP 
release n = 10 - . .... n = 11 
(minutes) sodium calcium sodium calcium 
Mean SD Mean SD Mean SD Mean SD 
PRE 131 2,8 2,4 0,24 137 3,6 2,5 0,17 
0,1 129 2,9 2,3 0,42 138 4,8 2,3 0,25 
5 129 2,1 2,2 0,32 133 7,9 2,2 0,28 
10 128 2,6 2,2 0,22 134 6,7 2,3 0,32 
15 128 2,8 2,2 0,36 134 7,1 2,2 0,24 
20 128 3,1 2,2 0,51 133 7,0 2,2 0,16 
Results are expressed as means+ s.D. 
No significant differences were-found 
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Serum Creatine Kinase (CK) activity (IU/litre) 
After release of the intial tourniquet there were no significant 
differences in serum CK activity between the two groups, although 
the range of values was very large. The CK activity rose with time 
for both groups, reaching maximum values three hours after 
tourniquet release (Figure 9). Thereafter, there was a linear fall 
in CK activity in both groups, reaching low levels about day 5 
(Figure 10). 
Some specimens of serum were analysed for CK isoenzyme activities 
after the first tourniquet. All three CK isoenzymes, MB, BB and MM 
were found in the serum after the first tourniquet application. 
(Data not shown) 
After removal of the second tourniquet on day six, there was again 
a rapid linear rise in serum CK activity. The rise was again 
maximum at three hours, but was significantly less than the rise 
after release of the first tourniquet. The ranges in CK activity 
were again very large and no significant differences were found 
between the normothermic and hypothermic groups (Figure 11). Serum 
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FIGURE 9 
Note the rapid rise 
tourniquet release. 
experiments in each 
of serum CK activity of both groups after 
Results expressed as mean for 10 
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group. 
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Note the rapid fall in serum CK activity during the six days 
after tourniquet release. 
Results expressed as mean for 7 experiments in the 
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FIGURE 11 
Note the rapid rise in CK activity after release of the 
second tourniquet and that peak levels are lower than after 
the first tourniquet. 
Results expressed as mean for 7 experiments in the 
hypothermic and 8 in the normothermic group. 
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Muscle phosphofructokinase activity, mole/min/g wet wt 
There was no significant difference in phosphofructokinase (PFK) 
activity either before or after either of the two tourniquet appli-
cations or between groups. (Figure 12) 
At sacrifice, four days after the second tourniquet, PFK activity 
in the ischaemic limb of the normothermic group was significantly 
lower than the PFK activity in the muscle of its control limb. 
There was no significant difference between the PFK activity in the 
control and the ischaemic limb of the hypothermic group. (Figure 
13) 
MUSCLE PHOSPHOFRUCTOKINASE 











~ Post Tourniquet 
CJ Pre Tourniquet 
HYPO NORMO HYPO NORMO 
FIRST TOURNIQUET SECOND TOURNIQUET 
Note there is no significant difference between the two 
groups before and after either tourniquet application. 
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FIGURE 13 
Note that there is no significant difference in PFK activity 
between the groups on day six. On day ten, the PFK activity 
is significantly lower in the ischaemic muscle of the 
normothermic group when compared to its control limb. 
Results expressed as mean+ S.D. PFK activity for 9 
experiments in both groups:-
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Muscle Glycogen content (mmole glucose equivalents/Kg wet muscle 
wt) 
The glycogen content of the control muscles of the normothermic 
group was significantly higher at the start of the experiment, and 
on days six and ten when compared to the control limb of the 
hypothermic group. This indicates two different pig populations, 
the group which had been randomly selected for the normothermic 
group appearing to have a greater glycogen storage capacity than 
those in the hypothermic group. 
There was a highly significant fall in glycogen content of the 
ischaemic muscle during the first tourniquet application in the 
normothermic group. No such fall occurred in the ischaemic muscle 
of the hypothermic group. During the second tourniquet applica-
tion, under normothermic conditions, there was a significant fall 
in glycogen content in the group previously subjected to hypother-
mia, but not in the normothermic group (Figure 14). 
Muscle glycogen content of the ischaemic limb of the normothermic 
group was significantly lower on day 6 than its control, whereas no 
such difference was found in the hypothermic group. At day ten the 
ischaemic limb of the hypothermic group had a significantly 
elevated muscle glycogen content. Muscle glycogen content of the 
control limbs of both groups and of the ischaemic limb of the 
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FIGURE 14 
Note the significant fall in muscle glycogen content before 
and after the first tourniquet in the normothermic but not in 
the hypothermic group. Note also the fall in muscle glycogen 
content of the previusly hypothermic limb but not in the 
normothermic limb during the second tourniquet application in 
which cooling was not employed. 
Glycogen results are expressed as mean+ S.D. (mmole glucose 
equivalents/Kg wet muscle weight) for 10 experiments in the 




















MUSCLE GLYCOGEN LEVELS 
TOURNIQUET AND CONTROL LIMB 
~ Tourniquet limb 
D Control limb 
* p<0,05 
* 
HYPO NORMO HYPO NORMO 
DAY SIX DAY TEN 
Note the different muscle glycogen levels in the two groups. 
The normothermic group has higher muscle glycogen content 
than the hypothermic group in the control limb on both day 
six and day ten. · At day six, the glycogen content of the 
ischaemic muscle in the normothermic group is significantly 
lower than its control. On day ten, muscle glycogen content 
in the hypothermic ischaemic limb is significantly higher 
than its control. 
Glycogen results. are expressed as mean + S.D. in (mmole 
glucose equivalent/Kg wet muscle weight) for 9 experiments in 
both groups. 
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Sudden death and muscle glycogen content 
During the course of the experiment, six pigs died suddenly within 
four days of the first tourniquet application. Of these six pigs, 
five were in the normothermic group and one in the hypothermic 
group. 
On analysis of the muscle biopsies, it was found that four of the 
normothermic and the one hypothermic pig had muscle glycogen levels 
less than 3 mmole glucose equivalents/Kg wet wt., after release of 
the tourniquet. Prior to tourniquet application, their muscle 
glycogen levels had been within the normal range. 
The other parameters measured temperature of lactate, pH, potassium 
and creatinine kinase during and after the first tourniquet. All 
fell within the experimental range. All results of this sub-group 
were removed from the data analysed and presented. 
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Temperatures °C 
Central (Nasal) Temperature °C 
There was no significant difference in nasal temperatures between 
the normothermic and hypothermic groups on release of the tourni-
quet (Table 4.4.). 
TABLE 4.4 CENTRAL TEMPERATURES (°C) 
Time after tourniquet NORMOTHERMIC HYPOTHERMIC 
Release GROUP GROUP 
(Minutes) n = 11 n = 10 
0 38,7 1,14 38,38 1,0 
2 38.6 1,14 38,33 1,05 
4 38,5 1.20 38,13 0,90 
6 38,5 1,23 38,1 0,90 
8 38,5 1,20 38,08 0,90 
10 38,5 1,21 38, 11 0,92 
15 38,5 1,22 38,05 0,96 
20 38,5 1,25 38, 11 0,96 
25 38,5 1,25 38,16 0,99 
30 38,6 1,26 38,25 0,88 
45 38,6 1,32 38,26 0,90 
60 38 ,5 1,32 38,21 0,90 
75 38,9 0,81 38,38 0,80 
90 38,9 0,80 38,51 0,86 
120 38,5 0,89 36,61 1,00 
180 38,4 1,47 38, 68 1,47 
Values are expressed as Means + s.n. -
Muscle Temperatures °C 
The muscle temperature of the ischaemic limb of both groups 
returned to control values within four minutes of tourniquet 
release. Thereafter the muscle temperature of the ischaemic limb 
of both groups became higher than that of the control limb. In the 
normothermic group, this rise became significant between 30 
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and 90 minutes post-tourniquet release and was still higher, 
although not significantly, at 3 hours (Figure 16). In contrast, 
the muscle temperature of the hypothermic group's ischaemic limb 
was never significantly above control values. (Figure 17) 
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FIGURE 16 NORMOTHERMIC GROUP 
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Note the significant elevation of the muscle temperature of 
the ischaemic limb above that of the control limb from 30 to 
120 minutes after tourniquet release. 
Results expressed as mean for 11 experiments. Acceptance 
intervals of the mean are shown between 30 and 120 minutes. 
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FIGURE 17 HYPOTHERMIC GROUP 
Note that there is no significant difference in muscle 
temperature between the ischaemic and control limbs after 
tourniquet release. 
Results expressed as mean for 10 experiments. 
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Skin Temperatures °C 
The skin temperatures of both the ischaemic hypothermic and 
ischaemic normothermic limbs returned to control levels within four 
minutes of tourniquet release. In the ischaemic limb of the normo-
thermic group there was an overshoot in skin temperature, above 
that of the control limb, which reached significant levels between 
45 and 90 minutes after tourniquet release (Figure 18). The skin 
temperature of the ischaemic limb of the hypothermic group also 
increased above that of the control limb for a short period after 
tourniquet release, but this increase was not significant (Figure 
19). 
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FIGURE 18 NORMOTHERMIC GROUP 
Note the significant elevation of the skin temperature of the 
ischaemic limb from 45 to 90 minutes after tourniquet 
release. 
Results expressed as mean for 11 experiments with acceptance 
intervals of the mean at 45, 60 and 90 minutes. 
SKIN TEMPERATURES POST TOURNIQUET RELEASE HYPOTHERMIC 
GROUP 
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Note that there is no significant difference in skin 
temperature between the ischaemic and control limbs after 
tourniquet release. 
Results expressed as mean for 10 experiments. 
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4.5 DISCUSSION OF THE RESULTS 
A. Principal Findings 
The principal findings of this study are that this method of hypo-
thermia application is both effective and safe and that hypothermia 
provides some protection to muscles exposed to tourniquet induced 
ischaemia. Evidence for the protective role of hypothermia is the 
slowing of glycogenolysis and hydrogen ion production during 
ischaemia, reduced potassium efflux from muscle and minimal 
inflammatory response on release of the tourniquet, a faster rate 
of biochemical and metabolic recovery, and reduced muscle cell 
damage. 
B. Safety and efficacy of this method of hypothermia 
The use of cold gel packs on the limb was found to be convenient 
and safe. Skin temperatures as low as 5°C (mean 9,3°C) and muscle 
temperatures as low as 11 °C (mean 16°C) were produced by close 
application of the cold packs insulated in a neoprene sleeve. No 
cases of ice burns, as evidenced by severe erythema or blistering, 
were seen in any of the ten animals who were subjected to 
hypothermia. 
During the days following the first tourniquet, the pigs who had 
undergone local limb hypothermia appeared to be in better general 
condition and to limp less when compared to the normothermic group. 
Similar findings were reported in limbs of dogs who had been sub-
jected to tourniquet application under hypothermia (Paletta et al. 
1961) and were considered to be due to decreased oedema formation 
in the ischaemic limb. 
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During the period of tourniquet application, no significant differ-
ences were found between the hypothermic and normothermic groups in 
serum creatine kinase activity, serum lactate, serum potassium, 
serum sodium and sodium calcium levels, nor in pH or nasal tempera-
tures. This implies that the ischaemic limb is effectively iso-
lated from the rest of the body by the tourniquet, as was also 
reported by Klenerman et al. (1980). Thus, the changes measured 
are due to local hypothermia and not to whole body cooling. 
C. Beneficial effects of hypothermia 
I. Local muscle metabolism 
Hypothermia produced a significant slowing in tissue metabolism as 
shown by the smaller fall in blood pH (Figure 7) and muscle glyco-
gen content (Figure 14) during ischaemia, and the smaller rise in 
serum lactate levels (Figure 6) in the hypothermic limbs on tourni-
quet release. This slowing of metabolism is believed to have a 
protective role in ischaemia (Seki 1980, Haljamae 1970, Hagberg et 
al. 1970). 
II. Muscle and skin temperatures 
The rapid return of skin temperature to control levels after tour-
niquet release is well documented (Sanders 1973, Modig et al. 1978, 
Dery et al. 1965, Harris et al. 1975). The elevation of the skin 
temperature of the ischaemic limb above control values has also 
been reported by some, but not all, workers (Modig et al. 1978, 
Sanders 1973). The finding in this study that the temperature of 
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the recently ischaemic muscle and skin of the normothermic group, 
but not of the hypothermic group, rises above that of the control 
limb, indicates the possibnility of acontinued inflammatory 
reaction. This supports the hypothesis that fewer breakdown 
products of ischaemia causing an inflammatory reaction are produced 
in the hypothermic muscle and skin. 
III. Local muscle damage 
The high tourniquet pressure (500 mm.Hg) applied to the relatively 
small muscle mass of the pig's forelimb, for three and then two 
hours, caused significant damage to the muscle. This was shown by 
the large rise in serum creatine kinase activity after release of 
the first and second tourniquets in both the hypothermic and 
normothermic groups. Unfortunately, whilst serum CK activity has 
been used as an accurate index of muscle damage in dogs (Chiu et 
al. 1976, Heppenstall et al. 1979) and in humans (Santavirta et 
al. 1978), it is a poor marker in South African Land race pigs. 
Mitchell and Heffron (1975) reported that the serum CK activity in 
this breed of pig varies considerably with age, time of blood 
sampling and especially the stress to which the animal is exposed 
at the time of sampling. Thus, in the present experiments, the 
ranges of serum CK activity taken from the pigs prior to tourniquet 
application were extremely large (80 - 800 IU/litre) and this may 
have obscured any beneficial effect of hypothermia. 
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As intracellular potassium levels (140 mmole/L) are much greater 
than serum levels (2, 5 - 4, 0 mmole/L), damage to tissue membranes 
causes potassium efflux, thereby raising serum potassium levels. 
Therefore, the higher serum potassium levels in the normothermic 
group even 20 minutes after tourniquet release indicates more 
severe muscle damage than occurred in the hypothermic group (Figure 
8). Continuing elevated potassium levels after tourniquet release 
have been reported by other authors (Klenerman 1980, Modig et al. 
1978, Jennische et al. 1982) and may indicate continuing muscle 
ischaemia. 
Muscle glycogen content, and the activity of the glycogen rate 
limiting enzyme phosphofructokinase, were used as indicators of the 
viability of the limb muscles. There were no significant differen-
ces in PFK activity before and after the two tourniquet applica-
tions, nor between the control and ischaemic limbs of both the 
hypothermic and normothermic groups at day six (Figures 12 and 13). 
However, the assay used only assesses the quantity of enzyme pre-
sent and not its in vivo functioning. Levels of PFK activity found 
were similar to that found in other mammals (E.A. Newsholme, Per-
sonal communication). At day ten, muscle PFK activity in the 
ischaemic limb of the normothermic group · was significantly lower 
than the control limb, possibly indicating damaged muscle tissue 
and destruction of the enzyme in the ischaemic limb. By contrast, 
at day ten, there was no difference in the PFK activity of the 
ischaemic and control limbs of the hypothermic group. Similarly, 
at day ten, the glycogen levels in the ischaemic limb muscle of the 
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normothermic group were lower than those of the control limb, 
further indicating damaged muscle tissue in the ischaemic limb. 
However, the fact that the muscle of the ischaemic limb of the 
hypothermic group had significantly higher stores than their 
control limbs (Figure 15), indicates that the muscle cells of the 
ischaemic limb of the hypothermic group were functioning normally, 
at least with regard to glycogen storage capacity. 
Thus, by subjecting the pig's forelimb to a second tourniquet, 
the muscle cells which were only marginally viable after the first 
tourniquet were furthe·r damaged. That the hypothermic group's 
muscle cells had been at least partially protected during the 
initial tourniquet was shown by the normal muscle PFK activities 
and glycogen content four days after the second tourniquet. The 
muscle cells of the normothermic group in contrast showed evidence 
of impaired biochemical function. 
The general elevation in glycogen content in the control limbs of 
both groups and the ischaemic limb of the hypothermic group is 
probably due to the fact that during the experiment the pigs were 
in individual cages and on an ad libitum diet. Prior to the ex-
periment they had had to fight for their food in communal pens. 
IV. Rate of recovery 
The ischaemic limbs of both the hypothermic and normothermic group 
developed reactive hyperaemia upon release of the tourniquet. This 
was shown by flushing of the skin, a rapid rise in skin and muscle 
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temperature and the maximum rise in serum potassium levels within 
the first minute after tourniquet release. The maximum elevation 
in potassium levels in the venous blood draining the limb on 
tourniquet removal, has been shown to correspond with maximum blood 
flow into the limb (Jennische et al. 1982). 
The hypothermic group had a significantly faster return to pre-
tourniquet levels of serum lactate, potassium and pH after the 
initial tourniquet. This indicates both a lesser degree of tissue 
damage and a more rapid rate of recovery. 
5. Premature Deaths 
The cause of the sudden deaths in five pigs (four normothermic and 
1 hypothermic) within three to four days of the first tourniquet 
application, is unknown. The only remarkable feature common to 
all was a marked fall in muscle glycogen after tourniquet removal 
(to 3 mmole/Kg wet wt). None of the surviving pigs showed this 
substantial drop in glycogen content. One animal, also in the 
normothermic group, died from septicaemic shock after the second 
tourniquet application, despite prophylactic penicillin. This 
animal had been sick prior to the second anaesthesia but this had 
gone unnoticed. 
It is interesting to note that, of the six early deaths, five were 
in the normothermic group. The data of all six animals were re-
moved from the final analysis of the results and thus, of the 
original 27 animals, only 21 have been included in the present 
study. 
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4.6 SUMMARY AND CONCLUSION OF THE EXPERIMENTS TO STUDY THE EFFECT OF 
LOCAL HYPOTHERMIA IN TOURNIQUET INDUCED MUSCLE ISCHAEMIA 
The application of cold gel packs was found to be safe and effective in 
reducing the ischaemic limbs' temperature for up to three hours. 
The application of hypothermia immediately prior to the tourniquet ap-
plication gave significant protection to the muscle. In the hypothermic 
group this was shown by 
1. A slowing of local muscle metabolism during the ischaemic 
period 
2. Less muscle damage during the ischaemic period itself, based on 
biochemical results immediately after tourniquet release. 
3. Equal muscle and skin temperatures in the ischaemic and control 
limbs after tourniquet release, indicating a smaller inflamma-
tory response 
4. An increased rate of tissue recovery after tourniquet release, 
based on biochemical results. 
5. Enhanced muscle viability ten days after the initial tourniquet 
application, based on the results of muscle biopsies. 
Thus, these studies provide strong evidence that local hypothermia could 
be a useful clinical modality for the "safe" prolongation of a pneumatic 
tourniquet application. However, further studies are required to assess 
its full role in clinical practice. 
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CHAPTER FIVE 
FUTURE DIRECTIONS FOR RESEARCH TO REDUCE TOURNIQUET-INDUCED 
NEUROMUSCULAR DAMAGE 
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INTRO DU CT ION 
The studies reported in the previous chapter have shown that hypo-
thermia, at least partially, protects muscle during tourniquet-induced 
ischaemia. However, it is clear that a number of additional problems 
exist in the use of the tourniquet and future research should direct 
attention to these problems. 
The five areas that I believe require attention are 
1. Determination of the "safe" tourniquet period 
2. Determination of the optimum tourniquet pressure 
3. Attention to the possible neurological damage caused by the 
tourniquet 
4. Studies of the effects of tourniquet application on clotting 
profiles and platelet aggregation 
s. Standardization of testing of pneumatic tourniquet apparatuses. 
Of these, I have tested a series of pneumatic tourniquet apparatuses and 
have drawn up a protocol for their testing in clinical practice. 
5.1. THE SAFE TOURNIQUET PERIOD 
What is a safe tourniquet time? 
Most authors agree with Klenerman (1962) that a limb which has had a 
tourniquet left on, either accidentally or as a "first aid" measure, for 
more than six hours, will almost certainly have to be amputated. There 
is, however, much debate in the literature regarding the length of time 
a tourniquet can be left on "safely". 
100 
Santavirta et al. (1978a) analysed 1000 consecutive lower limb opera-
tions performed under tourniquet at the University Hospital Helsinki, 
and found the average length of tourniquet duration to be 74 + 29 
minutes, ranging from 58 + 16 minutes for menisectomies to 131 + 11 
minutes for total knee replacements. 
Seki (1980) used hypothermia prior to tourniquet application, and sug-
gested four hours to be a safe time for upper limb ischaemia. On the 
basis of his metabolic studies, Klenerman suggested 3 hours to be the 
maximum safe tourniquet time (Klenerman 1962, 1980, 1982), as did 
Parkes (1973). In a review of 1500 patients who had tourniquets applied 
to the upper limb for two hours or less, Flatt (1972) concluded that two 
hours was a practical and safe duration for upper arm ischaemia. Shaw-
Wiglis (1971) found that after a tourniquet time of two hours, blood pH 
levels took progressively longer than 15 minutes to return to control 
levels and therefore also concluded that two hours was the upper limit 
of safety. 
Chiu et al. (1976) and Heppenstall et al. (1979), using blood pH and 
creatine kinase activity as markers of muscle damage in dogs, suggested 
that the total tourniquet time could be safely increased to three hours, 
if the occlusion was interrupted by 15 minutes after each hour of 
ischaemia. Santavirta et al. (1975b) have suggested that striated 
muscle withstands tourniquet ischaemia of two hours well. In contrast, 
Rorabeck and co-workers (1980) who studied nerve conduction velocities 
and recoveries during tourniquet application on dogs, suggested a maxi-
mum tourniquet time of only 75 minutes; less for patients with fat limbs 
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because of the greater shear stress. Heppenstall et al. ( 1979) agreed 
with this time limitation. Bruner (1970) suggested one hour to be a 
safe, but NOT harmless, tourniquet duration for upper limb surgery, 
whereas Eriksson (1981) even suggests that the tourniquet should be 
avoided al together in the sportsman undergoing knee surgery, as do 
Dobner and N.itz (1982). 
Thus, the various 'authorities' have widely differing views on the safe 
duration of a tourniquet application, ranging from its avoidance alto-
gether, to up to 4 hours. The intermittent release of the tourniquet as 
recommended by some, is viewed as clinically impractical by the majority 
of surgeons because of the poor operating field thus created and the 
difficulty in closing the odematous wound (Flatt 1972). 
5.2 THE OPTIMUM TOURNIQUET PRESSURE 
It is difficult to measure the pressure exerted by an Esmarch bandage 
tourniquet. There is no standard size for the bandage itself, although 
it is usually of the order of 2 m long x 76 mm wide x 1 mm thick. There 
is also no standard arm or leg to which it is applied, nor a standard 
surgeon to apply it. Griffiths and Hamilton (1970) found that four 
turns on a limb of 382 mm circumference exerted an average incremental 
pressure of 180 mmHg for each turn. However, pressures of up to 1000 mm 
Hg have been measured when the Esmarch bandage was put on 
'enthusiastically' over a small limb. 
Even using the calibrated pneumatic cuff tourniquet, there is no scien-
tific approach to the pressures that should be applied with regard to 
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the size and shape of the limb, the size of the cuff and the patient's 
systolic blood pressure, etc. Klenerman (1980) stated that "for the 
cuff pressure to equal blood pressure, the cuff width should exceed the 
diameter of the limb by 20%." However, the same author, (Klenerman 
1982), suggested that in normotensive patients who are not grossly obese 
or very muscular, a tourniquet pressure of double the systolic pressure 
is necessary to occlude the circulation and yet allow for pressure 
fluctuations during the operation. A pressure of 300 mmHg for the upper 
limbs and 500 mm.Hg for the lower limbs, as recommended by Campbell 
(1953), appears to be most commonly used. This is al so the pressure 
presently recommended by the Walter Kidde Company, makers of the widely 
used Kidde pneumatic tourniquet. Whilst this pressure is known to 
produce a bloodless field, it has been suggested that a tourniquet 
pressure 35 - 100 mmHg above the patient's systolic blood pressure would 
be more logical and safer (Sanders 1973, Klenerman 1980 and Adams 1976). 
These recommendations have been utilized by McEwen and McGraw (1982) to 
construct a microprocessor-based tourniquet coupled with a 
sphygmomanometer cuff measuring the patient's blood pressure. The 
tourniquet pressure is regulated to remain 50 mmHg above the patient's 
systolic pressure throughout the operation and thus the total tourniquet 
pressure used is greatly diminished. 
The development of such adaptive equipment is very important and could 
become standard equipment for all orthopaedic and casualty theatres, if 
it is shown to improve the safety of the tourniquet procedure. However, 
the expense of the unit, would probably limit its purchase in the fore-
seeable future. 
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Thus it appears that the arbitrarily assigned tourniquet pressures of 
500 mmHg for the lower limb and 300 mmHg for the upper limb are widely 
used at present. However, workers are now investigating whether such 
high pressures are necessary to create a bloodless field. In the future 
a more logical approach to setting a tourniquet pressure would take 
into account the patient's limb size, his or her systolic blood pressure 
and the properties of the pneumatic cuff itself. This would lessen the 
total tourniquet pressure applied and may help to decrease the damage 
caused to the underlying tissue. 
MEASUREMENT OF THE TISSUE PRESSURE EXERTED BY THE TOURNIQUET 
No-one has yet measured the actual tissue pressures exerted by the 
tourniquet. It is this pressure which occludes the artery and, as long 
as the pressure remains above arterial pressure, a bloodless field will 
result distal to the cuff. It should, theoretically, be possible to 
measure pressures under the tourniquet cuff and formulate an equation 
for the ideal cuff pressure for each individual patient. This equation 
would take into consideration the circumference of the patient's limb, 
the patient's systolic blood pressure and the pneumatic tourniquet cuff 
width. The equation would have to allow a safety margin for fluctua-
tions in the patient's blood pressure and hysteresis in the tourniquet 
apparatus itself. 
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METHODS OF MEASURING TISSUE PRESSURE 
Attempts at monitoring intramuscular tissue pressure have been made 
since Landerer in 1884 whose needle manometer technique, with various 
modifications (Burch and Sodeman 1965, McMaster 1941, Matsen et al. 
1976), has also been used to diagnose compartmental pressure syndromes 
(Whitesides et al. 1975, Matsen et al. 1976). 
The various techniques of intramuscular pressure measurement and their 
problems as related to pressure measurements under a tourniquet are : 
The Capsule Method 
Guyton et al. (1971) surgically implanted a porous capsule in the tissue 
to be studied. After leaving the area to heal for several weeks, the 
fluid within the capsule was assumed to have reached equilibrium with 
the surrounding fluid. A needle, to which was attached a pressure 
measuring device, was then inserted into the capsule. The pressure so 
measured was considered to be the interstitial tissue pressure of the 
area. 
This technique is obviously not well suited to tourniquet experiments 
because of the surgical implantation required, the long equilibration 
time and the fact that only one area can be monitored. The method has 
also been criticised because the observed pressure is influenced by the 
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osmotic gradient between the fluid inside and the fluid outside the 
capsule, which may alter under external pressure forces (Stromberg and 
Wiederhielm 1970). 
The Balloon Method 
In this technique, the tissue pressure is measured by a flaccid-walled 
balloon surgically implanted in the muscles and attached to a pressure 
monitor (Johnson et al. 1939). Various authors have also used this 
method to monitor the pressure, using the subject's veins as the "bal-
loon" (Ryder et al. 1944, Kjellmer 1964). 
The Wick Method 
Scholander (1968) described a simple wick technique which he used to 
study pressure change problems in various creatures, including dehydra-
tion in toads, tourniquet oedema in crocodiles and the hydrostatic com-
pensatory mechanism of snakes, amongst others. 
The wick catheter has also been used experimentally and clinically to 
measure and monitor intra-tissue pressures (Mubarak et al. 1976, Miller 
et al. 1979, Ladegaard-Pedersen 1970). The method is relatively simple, 
and is a modification of an open bore needle technique in which cotton 
fibrils protrude from the bore of a catheter assembly. This provides an 
extensive contact area for fluid equilibration and prevents ball-valve 
obstruction. The advantages are that it is minimally invasive, 
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provides for continuous monitoring and is cheap to produce. In 
addition, the wick itself cannot act as an osmometer (Mubarak et al. 
1976), because it is completely permeable. To prevent clotting around 
the wick fibrils and to decrease oedema formation, the threads are 
dipped in a solution of adrenaline and heparin before insertion. 
The disadvantages are that it theoretically measures only fluid tissue 
pressure, as opposed to total tissue pressure. The response time is 
slow, 4 - 10 minutes being necessary to equilibrate for pressure incre-
ments of 2 - 3 mmHg, and the technique can only be used in non-trauma-
tised tissue. 
Infusion Techniques 
These methods measure the pressure necessary to infuse fluid or air into 
the tissue. When there is excessive free fluid in the tissue, the solid 
elements are separated and fluid tissue pressure and total tissue pres-
sure become equal. 
The disadvantages with this method are that the measurements are not 
continuous. A manometer and an air fluid meniscus must be observed 
simultaneously to detect the pressure at which fluid first begins to 
flow into the tissue, and thus there is the possibility of significant 
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observer error. Satisfactory measurements can also only be ma.de in non-
traumatised tissue (Snashall and Boother 1974). Mubarak et al. (1976) 
maintain that this technique is inaccurate, tending to over-read at low 
pressure and under-read at high pressures. 
Matsen et al. (1976) described a continuous infusion technique using an 
infusion pump which keeps the needle open with as little as O, 7 cc of 
fluid per day. The authors claim this to be a safe, accurate and simple 
method of continous monitoring of intra-tissue pressure for the recog-
nition of compartmental pressure syndromes. 
Solid State Pressure Probe 
When used to monitor intra-muscular pressure, Mubarak et al. ( 1976) 
found solid state pressure probes to be highly dependent on temperature. 
Pressure recordings of the same muscle compartment often gave quite 
different results with little consistency in the readings. 
CONCLUSIONS 
Various methods for measuring tissue pressure are available and all 
appear to have their problems and limitations. A useful contribution to 
the debate on safe tourniquet pressures would be the standardization of 
pressures needed for the variety of subject shapes one encounters in 
clinical practice. I suggest that the actual pressures exerted by the 
different types of tourniquet around differently shaped limbs should be 
measured by whichever of the above techniques is found to be most appro-
priate. My own feeling is that the Wick method, as described by 
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Scholander (1968) and modifed by Mubarak et al. (1976), is the best 
method available. 
5. 3 ADDITIONAL STUDIES OF PARTIAL SKELETAL MUSCLE DENERVATION AFTER 
TOURNIQUET PROCEDURES 
There are three studies which show that 60-70% of patients have partial 
denervation in quadriceps muscle after menisectomy under tourniquet 
(Weingarden et al. 1979, Saunders et al. 1979, Dobner and Nitz 1982). 
The electromyographic abnormalities that were reported included 
spontaneous action potentials, sharp 'a' waves, fibrillation po~entials 
and motor unit deficits. 
These studies have important implications for the future use of the 
tourniquet. A sportsman who has been subjected to an operation in 
which a tourniquet was applied, even for a few minutes, may have had his 
ability for rapid rehabilitation to full muscular strength seriously 
prejudiced. Any weakness of the femoris quadriceps, for example, may 
predispose to a further, and perhaps more severe, injury should the 
athlete return to sport prematurely. Thus it is important that further 
trials be carried out to ascertain if the incidence of electromyographic 
(EMG) ,abnormalities is as high as that reported six weeks after 
menisectomy under tourniquet. Femoral nerve conduction studies should 
also be carried out at the same time. 
The quantitative effect that any denervation has on the muscle 
functioning could be recorded by means of an isokinetic testing machine 
(Cybex, Lumex Inc., New York, U.S.A.). Follow-up of abnormalities would 
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include monthly muscle and electromyographic testing until full recovery 
has occurred. 
A study of this nature would be of great importance in ascertaining: 
1. the percentage of patients who have unrecognized nerve damage 
after tourniquet procedures, and 
2. the correlation between the nerve damage and objectively-
measured muscle function. Both these factors are of utmost 
importance in deciding whether or not a sportsman should have 
surgery under tourniquet. 
5.4 STUDIES ON THE EFFECTS OF TOURNIQUET APPLICATION ON CLOTTING 
PROFILES AND PLATELET AGGREGATION 
Various authors have proposed that platelet aggregation is affected by 
tourniquet application (Stebhens and Biscoe 1967, Zahavi et al. 1980, 
Chen et al. 1982). Patients with ischaemic heart disease were found to 
have a significant increase in platelet aggregation after tourniquet 
application, due to a decrease in prostacyclin generation and an in-
crease in thromboxane A2 liberation (Chen et al. 1982). Heal thy sub-
jects, in contrast, showed an increase in prostacyclin generation as 
well as thromboxane liberation; changes which would tend to oppose 
platelet aggregation. 
This finding may account for differences in the prevalence of deep vein 
thrombosis reported after tourniquet application. Some authors have 
reported an increased (Price et al. 1980), whilst others have reported a 
decreased prevalence of deep venous thrombosis (Klenerman et al. 1977, 
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Fahmy and Patel 1981, Kroese and Stiris 1976, Simon et al. 1982), when 
operations performed under tourniquet were compared with those performed 
without tourniquets. 
Clearly, additional studies are required to answer these questions. One 
approach would be to study patients who are scheduled to undergo surgery 
on the lower limb in which a tourniquet is to be used. A full medical 
history would be taken prior to the operation with an emphasis on signs 
and symptoms of ischaemic or peripheral vascular disease. Blood samples 
for platelet aggregation and clotting studies would be taken prior to 
tourniquet release S, 30 minutes and 60 minutes after tourniquet re-
lease. The study could be extended to investigate the correlation be-
tween clotting parameters and the incidence of deep vein thrombosis as 
detected by Doppler, fibrinogen or venogram studies. 
This study would show whether changes in the blood clotting profiles are 
dependent on the pre-operative status of the patient. If found to be 
so, surgeons would have to review seriously the advisability of the use 
of the tourniquet in certain patients. If necessary, such patients 
might have to be pre-treated with an anti-platelet aggregation drug, 
such as low dose aspirin. 
S. S THE STANDARDISATION OF TESTING PNEUMATIC TOURNIQUET APPARATUSES 
Introduction 
Several authors (Bruner 1951, Hamilton and Sokoll 1967, Prevoznik 1970, 
Fry 1972, Calderwood and Dickie 1972) have reported nerve damage caused 
by faulty tourniquet gauges. On testing, some of these gauges 
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under-read by as much as 500 mmHg. Fry (1972) conducted random checks 
on tourniquet equipment in every-day use and found 20 of 31 to be 
defective. 
Certain manufacturers (Walter Kidde & Co. Inc.) recommend that their 
apparatus should be tested monthly against a mercury manometer. These 
tests consist of recording the accuracy of the tourniquet gauge reading 
at pressures of 100 and 300 mmHg and the ability of the apparatus to 
hold a constant pressure of 300 mmHg for 20 minutes. Hurst et al. 
(1981) conducted such tests on machines in routine use and found two out 
of seven to be defective. The pressure applied by one machine increased 
by 500 mmHg after only ten minutes. A more stringent testing procedure, 
in use in Vancouver Hospital, Canada, was outlined by McEwen (1981). 
I, therefore, decided to draw up a protocol which included most of the 
described tests and to study the tourniquet apparatuses in clinical use 
in six hospitals in the Western Cape. 
Materials and Methods 
The test gauge was a digital readout pressure transducer (see Equipment 
Chapter 4. 2A) especially constructed for the experiments. 
calibrated regularly against a mercury manometer. 
It was re-
A copy of the testing protocol and the pre-marked form, together with a 
watch and pen, were taken to the surgical theatres where the Kidde (reg) 
apparatus was in regular use. The Kidde tourniquet apparatus (Model 
400) consists of a gauge which can be pre-set to deliver the required 
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pressure to an inflatable cuff. The pressure is produced by the vapori-
sation of a volatile liquid (freon) contained in the reservoir of the 
apparatus. This reservoir is supplied by freon contained in a renewable 
container connected at the rear. The Kidde pneumatic tourniquet appara-
tus was chosen for the study as it is the most popular of the automatic 
apparatuses in clinical use in the Western Cape. 
The testing protocol was as follows : 
The Kidde tourniquet apparatus was connected to the test pressure gauge 
by a three-way tap. The accuracy of the apparatus gauge was checked by 
comparing it to the pressure recorded on the test gauge, when the ap-
paratus gauge was set at pressures of 100, 200, 300, 400, 500, 600 and 
700 mmHg. 
noted. 
The effect, if any, of tapping on the tourniquet gauge was 
A pressure of 500 mmHg was then set on the tourniquet gauge, the test 
gauge pressure noted and the three-way tap turned to place the test 
gauge out of circuit. After 10 minutes, the three-way tap was opened to 
the test gauge and the pressure reading again recorded. The difference 
between the initial and second readings was taken to be a measure of the 
ability of the apparatus to maintain a pre-set pressure (i.e. its 
stability). 
In the next test a rubber bulb from a sphygmomanometer was placed in 
parallel to the test gauge and tourniquet apparatus. A pressure of 300 
mmHg was set on the tourniquet gauge and the true pressure recorded from 
the test gauge. Using the bulb, the pressure in the apparatus was 
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gently increased, thus imitating a slow continued pressurization of the 
pneumatic cuff due to a defective valve. A plateau pressure was reach-
ed, indicating blow-off of the safety valve and this pressure was recor-
ded from the test gauge (Reading 1). The pressure in the system was 
then released via the bulb, imitating a leak in the cuff, until a second 
plateau pressure was reached which indicated the pressure stabilising 
mechanism had been activated (Reading 2). The difference between the 
two readings was taken as an indication of the state of the release 
valve mechanism, the so-called hysteresis of McEwan (1981). The test 
was then repeated, commencing at a tourniquet gauge reading of 500 
mmHg. 
The final test was a thorough visual inspection of the apparatus to 
check that the filling reservoir was not overfilled and that the pres-
sure tubing, connectors, gauge and cuffs were in good condition. 
Results of a survey of hospital tourniquet apparatuses 
Six hospitals were visited and a total of thirteen Kidde Tourniquet 
apparatuses checked (Table 5.1). The following were found: 
Accuracy - Acceptable accuracy was taken as+ 5% as recommended by the 
Kidde manufacturers. The gauges of eight machines (62%) tended to 
consistently under-read over the range of pressures tested (Figure 20); 
one machine under-reading by 350 mmHg. 
The effect of tapping the gauge - Acceptable effect+ 15 mmHg. All the 
machines passed this test. 
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Stability - Acceptable stability + 10% after 10 minutes. All but one 
machine maintained the set pressure. 
Release valve mechanism (hysteresis) - The acceptable difference between 
readings at both 300 mmHg and 500 mmHg was taken as 250 mmHg (McEwan 
1981). Eight machines (62%) showed unacceptable hysteresis. 
Visual - One machine had the wrong connectors fitted and two machines 
had reservoirs which were overfilled. One machine had had a release 
valve placed in line between the tourniquet apparatus and the cuff. 
This effectively meant that · the pressure gauge was out of circuit and 
thus not monitoring the actual cuff pressure. 
TABLE 5.1 RESULTS OF TESTING OF TOURNIQUET APPARATIJSES (n=l3) 
TEST ACCEPTABLE NUMBER PERCENTAGE 
ACCURACY FAILED FAILED 
Accuracy + 5% 8 62 -Tap + - 15 mmHg 0 0 Stability + 10% 1 8 
Release Valve Mechanism 250 mmHg 8 62 
Visual 3 23 
Discussion and Recommendations 
The manufacturer of the Kidde pneumatic tourniquet apparatus recommends 
regular monthly checks. Various authors also recommend the checking of 
the pneumatic tourniquet accuracy against mercury manometer before each 
operation (Hamilton and Sokol! 1967, Bruner 1970, Flatt 1972). It would 
seem, however, that these recommendations are not observed, at least in 
hospitals in the Western Cape, as only two out of 13 apparatuses tested 
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were found to be satisfactory for all the criteria. This agrees with 
other random surveys (Fry 1972, Prevoznik 1970, Rorabeck 1980). 
Some of the faults found in this survey could be easily remedied as the 
inaccuracy of the tourniquet gauges tended to be linear at all pressures 
(Figure 20). Thus, re-zeroing of the needle would restore complete 
accuracy. However, other faults rendered some machines dangerous, as in 
the case where a separate pressure release valve had been placed between 
with the cuff and the tourniquet gauge or where the release valve me-
chanism was faulty, as found in 8 (6_2%) of the apparatuses tested. 
This study, therefore, showed that there is a need for a series of regu-
lar checks to be performed on the pneumatic tourniquet apparatus. I 
suggest the inclusion of the testing protocol into a surgical theatre's 
checklist, would be another way to lessen the risk of the tourniquet 


















ACTUAL AND IDEAL TOURNIQUET 
APPARATUS PRESSURE MEASUREMENTS 
Ideal 
<>--~ Measured 
0 100 300 500 700 
APPARATUS GAUGE PRESSURE mmHg 
Note the true pressures measured on the test gauge are 
linearly higher at all measured pressures. 
Results expressed as mean for thirteen pneumatic apparatuses, 
plus or minus standard deviation. 
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CHAPTER SIX 
OVERALL SUMMARY AND CONCLUSIONS 
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1. The protective role of hypothermia during tourniquet-induced 
muscle fschaemia 
This study has established that cold polyglycol gel packs are easy and 
safe to apply to the tourniquet limb; they produce very adequate local 
hypothermia which provides partial protection to the ischaemic limb 
muscles. 
However, a weakness of this study was that it was based on the measure-
ment of metabolic and biochemical parameters. An improvement would have 
been to study morphological differences between the hypothermic and 
normothermic ischaemic limbs, using the electron microscope. It would 
have been of interest to combine such a study with histological evalua-
tion of the effect of local hypothermia on the nerve damage caused by 
the application of a tourniquet. It may then have been possible to 
correlate observed changes with an electromyographic study of the muscle 
innervated by that nerve. 
A study such as that mentioned above would be important in further 
clarifying the protective role of local hypothermia during tourniquet 
application. 
2. Further Clinical Studies 
Clinical studies are indicated to evaluate various aspects of the 
pneumatic tourniquet application, namely: 
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A. The clinical role of hypothermia, produced by the application 
of cold gel packs, in decreasing neuromuscular damage and 
extending the "safe" tourniquet time. 
B. The clotting and platelet aggregation changes which occur with 
the use of the pneumatic tourniquet. The effect of local 
hypothermia on these parameters could also be studied 
c. The feasibility of creating an equation to enable the surgeon 
to individualize the tourniquet pressure for each patient. 
Thus, the total tourniquet pressure used during the operation 
could be safely decreased. 
D. The incidence of electromyographic abnormalities in the 
muscles of patients after operations involving the use of the 
tourniquet. This could be objectively correlated to muscle 
weakness and the time taken to full recovery. 
Thus, whilst much work has been carried out on the effects of the 
pneumatic tourniquet, much still requires to be investigated. It is 
hoped that further clinical studies along the lines indicated will shed 
more light and make what has become a routine surgical procedure safer 







I. Sodium and Potassium Levels 
4. 5 ml of venous blood was collected in a heparinised Vacucontainer 
(Beston - Dickinson) and agitated gently for a few seconds. The sample 
was then placed in the fridge ( 4 °C). Within two hours of collection 
the tube was centrifuged at 2000 R.P.M. for 15 minutes, and the serum 
pipetted off and stored in the fridge. 
The sodium and potassium levels in the serum were measured using a 
flame photometer (Instrumentation Laboratory Flame Photometer 543), 
with lithium as the standard reference •• 
II. Calcium Levels 
1\ ml of blood was placed in an Eppendorff tube and allowed to clot. 
The tube was then centrifuged at 2000 R.P.M. for 15 minutes. The 
supernatant serum was pipetted off and placed in a fresh Eppendorff 
tube, stoppered and placed in the freezer (-20°C) until analysis. The 
total calcium was measured using an Atomic Absorption Spectrophotometer 
(Varian model AA 127 5) at an · absorption of 422. 7n .m. , with a plasma 
standard (Versatol General Diagnostics) diluted ' 1 in 30 in Harthaium 
(B.D.H.) (LalOOg/ml). 
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III. Hydrogen Ion Concentration (pH) 
2 ml of blood was drawn into a heparinised syringe. A needle was 
attached and bent over to prevent equilibration of the blood with room 
air. The sample was then analysed within five minutes using a pH meter 
(Radiometer M73, Copenhagen) coupled with a BM5 Mk2 Micro System. The 
apparatus was standardised using pre-made solutions of pH7, 383 and pH 
6,841. 
IV. Lactate Levels 
1. 2 ml of blood was placed in a previously weighed plastic test tube 
containing 2 ml of 0,6N perchloric acid (PCA). The tube was agitated 
to mix thoroughly, weighed and placed in the fridge. Within two hours 
the lactate was spun at 2000 RPM for 15 minutes and the supernatant 




Cuvettes were made up using 3 blanks and 2 standards as follows 
Std Blank Test 
Hydralazine buffer 1,0 ml 1,0 ml 1,0 ml 
NAD 0,1 ml 0,1 ml 0, 1 ml 
PCA O, 1 ml 
LDH 0,01 ml 0,01 ml 0,01 ml 
Supernatant O, 1 ml 
Standard (Std) 0,1 ml 
The solutions were mixed (vortex mixer Fissons BP 931263) and allowed 
to equibrate to room temperature for 30 minutes. 
The absorption at 340 nm was then read using a spectrophotometer 
(Beckman Instruments, Spectrophotometer Model 35), zeroed against 
distilled water. 
The following calculation was then used 
Total volume in cuvette X vol. of P.C.A. + blood X 1 
Volume of supernatant vol blood 6,22 
6,22 = molar extinction coefficient of NADH) 
to give the concentration of lactate in /mole/ml 
123 
v. Creatine Kinase (CK) Activity 
6 ml of blood was callee ted in a tube with an inert barrier and clot 
activating medium at the base (vacucontainer SST6510), left to clot at 
room temperature for half an hour, and then placed in the fridge. The 
blood was centrifuged at 2000 rpm for 15 minutes, the serum decanted 
off and stored in the fridge until assayed within five days. Porcine 
CK activity is reported to be stable in stored serum \llltil well after 
five days 
with 50 
(Mitchell et al 1975). 
J.Jl of distilled water, 
15 J.Jl of the sample was then diluted 
350 J.J 1 of reagent (NAC activated 
Monotest, Boehringer Mannheim cat No. 181188) was added and the 
absorption at 340 nm read · on a . spectrophotometer (Centachem System 
400). 
MUSCLE ASSAYS 
I. Glycogen Content 
The weighed muscle sample was macerated with 1 ml KOH ( 40%) and added to a 
plastic tube. The tube was placed in a water bath at 100°C for 30 minutes, 
after which 4 ml of 95% ethanol was added to the solution and the tube was 
again placed into the water bath for 30 minutes to precipitate the glycogen. 
The solution was left overnight in the fridge (4°C) and then the supernatant 
removed after centrifuging (10 minutes at 5000 r.p.m.). One ml 2N HCl was 
added to the precipitate to hydrolyse the glycogen to glucose and the 
solution was placed in the water bath at 100°C for 3 hours. O, 2M Tris 
buffer was added to the solution to bring the pH to 7, 5, 200 JJl of the 
resultant was mixed with 2, 8 ml of the reagent mix (see below) and the 
absorption read at 340 nm (Beckman Spectrophotometer Model 35). The above 
procedure was carried out over three successive days. 
124 
REAGENT MIXTURE 
Reagent Mixture Per Cuvette 
Tris buffer O, 2M pH 7,5 1ml 
ATP 20 mM 0,1 ml 
MgCl26H20 1M 0,1 ml 
NADP 1% (TPN) 0,1 ml 
Distilled Water 1,5 ml 
2,8 ml 
200 J.Jl of reagent mix was also added to 200 J.Jl of lmM glucose standard and 
200 )-11 of distilled water (used as the blank) and their absorptions at 340 
nm recorded. 
10 1 of HK/G6PDH suspension (Boehringer Cat. No. 127825) was added to each 
cuvette and after standing for 30 minutes the absorption at 340 nm again 
read. 
The glycogen content was calculated from the following formula. 
(Optical Density difference - ) - baseline) x 3(Vol in cuvette) 
( 0,414 ) ) wet wt mg 
This gives the glycogen content in mmole glucose equivalents/kg wet weight. 
The recovery was calculated by Std reading x 100 
0,414 
The recovery during the experiments was greater than 92%. 
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II. Phosphofructokinase (PFK) Activity 
The muscle sample was weighed and diluted 1 in 10 with a homogenating buffer 
consisting of 
50 mM triethanolamine RC! 
2 mM MgCl2 
1 mM EDTA 
30 mM Mercaptoethanol 
2 mM glycerol for stabilising 
1 mM 2-oxoglyturate effect 
Keeping the tube surrounded by ice, the muscle was then homogenated for 10 
secs. (Ultra TURRAX-TP18/10 Janke and Kunkel - Germany, 
sonicated (Sonifier Model B-12, Branson Sonic Power 
setting 4) and 
Company) for 15 
seconds. It was then centrifuged for 1 minute at 4°C (2000 r.p.m.) and the 
supernatant fluid decanted off for measuring. 
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Next 10 1 of the supernatant fluid was added to a cuvette with the reagent 
mixture which consisted of : 
1 ml Tris - HCl - KC! - MgC1 2 - BSA buffer pH 8,2 
10 1 ATP 100 mM 
10 1 AMP 200 mM 
10 1 NADH 100 mM 
10 1 F-6-P 100 mM 
* 5 1 aldolase 
* 5 1 x glycerin - 3 - phosphate dehydrogenase 
* 5 1 1:10 Trisephosphate isomerase 
* added just prior to the addition of the supernatant fluid 
The mixture was agitated and read to extinction at 340 mm, (Beckman 
spectrophotometer - Model 35). The milli Absorbance Units per minute 
was calculated from the slope of the curve. 
The PFK activity was calculated according to the equation 
X 1000 X 1 x Vol Homo-m,A,U, 
6,2 
x total vol cuvette (ml) 
1000 Vol extract used 
(ml) 
tissue wt genising 
(mg) medium 
m,A,U, - milli absorbance units in one minute at 340 n.m. 
This gave the value of PFK activity in mol/min/g wet wt, 
Storage of reagents 
(ml) 
ATP, AMP, NADH, and F-6-P were kept in the freezer (-20°C) and the remaining 







The data were analyzed by an analysis of variance. Homogeneity of variance 
was tested using Bartlett's criteria, where the variances lacked homogeneity 
at p 0,05 the raw data was transformed (either squared root or log). 
Acceptance intervals of the mean (allowance) was calculated using: 
( 1 + ]:_) 
n1 nz 
A = Acceptance interval 
p = Probability value 
t = Student's t value 
MS = Mean square within the cell 
n1 = Sample size of one mean 
nz = Sample size of second mean 
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